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Abstract
A Comparison of MMPI-2-RF Profiles of Outpatients with Reported Chronic Medical
Conditions, Reported Disability, or Psychological Ailments
Natalie Hicks, M.S.
Major Advisor: Radhika Krishnamurthy, Psy.D., ABAP
Past personality assessment research using MMPI instruments has examined their use in a
variety of contexts, including in healthcare settings. The utility of the more recently
developed Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2RF), however, has not been examined in these contexts to the same degree. The present
study evaluated differences between MMPI-2-RF scores in a sample of 154 adult
outpatient community mental health clients who (a) reported a preexisting physical
condition in conjunction with psychological symptoms (n = 66), (b) were either in the
process of applying for or were already receiving Social Security disability compensation
(n = 30), or (c) reported purely psychological disturbance (n = 58). Multivariate analysis
revealed significant differences among the scores on six (12.2%) of the 49 MMPI-2-RF
scales of interest in this study (i.e., all scales excluding the two Interest scales).
Subsequent univariate and post-hoc analyses demonstrated differences between the
Social Security disability compensation group and comorbid complaints group on three
(6.1%) of the 49 scales examined, between the Social Security disability compensation
group and psychological complaints group on six (12.2%) of these 49 scales, and
between the psychological complaints and comorbid complaints on one (2%) scale.
Hierarchical linear regression results revealed that the three scales identified as
iii

significantly different between the Social Security disability compensation and comorbid
complaints groups accounted for 13% of the variance in score differences between these
groups. A second hierarchical linear regression analysis demonstrated the six scales that
were significantly different between the Social Security disability compensation and
psychological complaints groups collectively accounted for 30% of the variance between
these groups. Simple linear regression results indicated the one scale found to be
significantly different between the psychological complaints and comorbid complaints
groups accounted for 4% of the variance between these groups. Overall, the nature of the
differences that emerged between the three groups was such that: (a) the Social Security
disability compensation group reported a broad array of symptoms across several
domains, including experiences of negative affect, internalization of emotion, somatic
concerns, pessimism, and disturbances in interpersonal interactions; (b) the comorbid
conditions group reported both somatic and psychological symptoms consistent with the
nature of their presenting concerns; and (c) the psychological complaints group primarily
reported emotional dysfunction with fewer somatic symptoms than those reported by the
other two groups. Contributions, limitations, and future research directions are discussed.

Keywords: MMPI-2-RF, personality assessment, chronic health, disability compensation.
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Introduction
The distinction between mind and body and the connection between them has
been a persistent issue addressed throughout the history of psychology. Positions taken
on this issue generally fall within two camps: monism or dualism. Monism, or the belief
that everything in existence, including human cognitions and behaviors, can be explained
in terms of matter, was the reigning opinion until dualism was introduced in
philosophical literature in the mid-1600s by René Descartes. Dualism posits that both
physical and mental events exist and are governed by different principles. Once the
assumption is made that there are both physical and mental events, the question then
becomes how the two are connected. While there are several forms of dualism, that which
is most related to the current study is interactionism, which claims that the body and mind
interact; that is, the mind influences the body and vice versa. This was the position taken
by Descartes, as well as the psychoanalysts, including Freud (Hergenhahn & Henley,
2013). The interconnection between psychological and physical functioning has long
been recognized in psychology. More recently, the American Psychological Association
(APA) reported that as many as 70% of primary care visits are driven by patients’
psychological problems, including anxiety, depression, and stress (2014). This briefing
also noted that co-occurring mental disorders, such as anxiety and depression, can worsen
the courses of several chronic illnesses, including cardiovascular disease, diabetes,
asthma, epilepsy, cancer, and obesity. Furthermore, psychological distress has been found
to weaken the immune system (APA, 2014).

ix

The understanding that physical and mental health interact and influence each
other sparked further research examining various facets of personality on health. This
connection also led to the later development of various subfields within psychology and
medicine such as health psychology and integrated behavioral healthcare. Psychological
assessment findings have shown the effects of various personality traits and
psychological symptoms on health, as well as health conditions’ effects on psychological
factors such as mood. The Minnesota Multiphasic Personality Inventory (MMPI)
instruments in particular have been widely used in such contexts, including evaluating the
impact of physical conditions on psychological functioning and in disability evaluations.
While the use of the MMPI-2 in defining clinical profiles related to specific health
conditions and Social Security disability evaluations has been widely documented (e.g.,
Deardorff, Chino, & Scott, 1993; Livingston, Jennings, Colotla, Reynolds, & Shercliffe,
2006), the use of the MMPI-2-RF for these purposes is not as prevalent in the literature,
given that this instrument is the most recent version and its research base is still
developing. Specifically, a comparison of MMPI-2-RF profiles of individuals with
chronic health conditions and those seeking or receiving Social Security disability
compensation has not been made, indicating a need for further investigation. The current
study examined similarities and differences in MMPI-2-RF profiles of outpatient
psychotherapy clients with reported comorbid physical and mental health-, disability-, or
psychological condition.

x

Review of Literature
Relationship Between Physical and Mental Health
The connection between physical and mental health has been well-documented in
the psychological literature and is determined to be quite strong (Ohrnberger, Fichera, &
Sutton, 2017). For instance, stress and other psychosocial factors (e.g., chronic anger,
depression, optimism, social isolation versus support) have been shown to have
psychobiological effects on the development and progression of physical illness and
disease, health behavior and prevention, and psychosocial aspects of healthcare.
Similarly, physical illnesses and their associated medical/surgical care impact several
aspects of the lives of patients and their families, including physical distress, emotional
adjustment, social and vocational roles, and disability (Smith, Williams, & Ruiz, 2016).
The biopsychosocial model proposed by Engel (1977) addresses these relationships, as it
posits that disease and its treatment are best understood in the context of considering not
only the individual but also the interpersonal, social, and cultural levels in which the
individual operates.
Several mental disorders (e.g., bulimia nervosa, bipolar I disorder, major
depressive disorder [MDD], borderline personality disorder) are associated with a greater
risk for attempted and completed suicide than that of the general population.
Traditionally, there has been an opinion that suicide and unintentional deaths were a
major contributor to excess mortality in individuals with mental illness. Specifically, it
has been found that the mortality of individuals with severe mental disorders, including
schizophrenia and related psychotic disorders, bipolar disorder, and MDD is in excess
1

compared to that of the general population (Brown, Kim, Mitchell, & Inskip, 2010;
Vancampfort et al., 2015). For schizophrenia in particular, it is suggested that excess
unnatural deaths are inherent to the disorder, while excess natural deaths are best
explained by differences in exposure to environmental risk factors (Kendler, 1986).
However, most mental illnesses do not directly lead to death. Data from Lawrence,
Hancock, and Kisely (2013) indicate that roughly 80% of excess deaths in those with
mental illness are instead due to comorbid physical health conditions. Additionally,
Brown et al. (2010) examined the 25-year mortality of individuals with schizophrenia and
determined that most deaths over this timespan were from common causes seen in the
general population (e.g., circulatory disease, respiratory disease, and cancer).
Cardiovascular mortality of schizophrenia in particular was found to have increased over
the past 25 years, relative to the general population, and a large portion of the excess
mortality of this sample was likely attributable to effects of cigarette smoking (224
members of the N = 370 sample were cigarette smokers at the beginning of the study).
Individuals diagnosed with mental illnesses have greater risk of preventable chronic
physical illnesses, as well as decreased life expectancy of up to 30 years (Brown et al.,
2010; Lawrence et al., 2013; Rosenbaum et al., 2015; Vancampfort et al., 2015).
The mortality rate of individuals with mental health conditions is greater than that
of the general population, with cardiovascular disease (CVD) being the leading cause of
death in those with a mental health condition or conditions; thus, a great deal of research
has focused on this particular relationship. Regardless of mortality, even the rates of
development and progression of CVD have been found to be higher in individuals with
2

mental health conditions than in individuals without. Like Brown et al. (2010),
Vancampfort et al. (2015) focused on schizophrenia and other psychotic disorders,
bipolar disorder, and MDD, and the prevalence of metabolic syndrome (MetS) and its
components, which are highly predictive of cardiovascular disease in individuals with
these disorders. This meta-analysis indicated that approximately one third, or 32.6%
(95% CI = 30.8%-34.4%), of this psychiatric population had MetS, and their relative risk
for developing MetS was 1.58 times greater than that of the general population.
Prevalence rates for MetS were consistently elevated for each diagnostic subgroup
without significant differences across schizophrenia, bipolar disorder, and MDD.
Rosenbaum et al. (2015) also studied the prevalence and risk of MetS and its
components but in individuals with posttraumatic stress disorder (PTSD). The results of
this meta-analytic study determined that 38.7% (CI = 32.1%-45.6%) of the 9,673
individuals with PTSD had MetS, and their relative risk for developing MetS was
approximately twice as great than in age-and gender-matched controls in the general
population (RR = 1.82; 95% CI = 1.72-1.92, p < .0001). High rates of MetS components,
including abdominal obesity (49.3%, 95% CI = 29.7%-69.0%), hypertension (76.9%,
95% CI = 67.9%-84.8%), hypertriglyceridemia (45.9%, 95% CI = 12.2%-81.9%),
hyperglycemia (36.1%, 95% CI = 18.8%-55.6%), and low high density-lipoprotein
(HDL)- cholesterol levels (46.4%, 95% CI = 26.4%-67.0%) were also found for
individuals with PTSD.
Lawrence et al. (2013) conducted a comparable study examining life expectancy
for people with psychiatric disorders in Western Australia. This study demonstrated that
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the gap in life expectancy for such individuals compared to the general population
increased between 1985 and 2005, from 13.5 to 15.9 years for men and from 10.4 to 12.0
years for women. In other words, men with psychiatric disorders have a life expectancy
that is roughly 16 years less than men in the general population, while the life expectancy
of women with psychiatric disorders is 12 years less than women in the general
population. Like Brown et al. (2010), Lawrence et al. (2013) also established that excess
mortality was generally attributed to physical health conditions, particularly
cardiovascular disease, respiratory disease, and cancer. Exceptionally large increases in
life expectancy gaps were found for both men and women with stress or adjustment
reactions as well as psychoses other than schizophrenia, while the widest gap in life
expectancy (i.e., greater than 20 years) was seen in individuals with primary diagnoses of
a substance use disorder. The majority of excess mortality in these cases was attributable
to heart disease, cancer, and liver disease, consistent with the fact that misuse of
substances is an established risk factor for cardiovascular disease and several forms of
cancer. Overall, these findings suggest that the gap in life expectancy between individuals
with psychiatric disorders and the general population is higher than those of other
disadvantaged groups. For instance, while the life expectancy for lifelong smokers is
approximately 10 years less than that of non-lifelong smokers (Doll, Peto, Boreham, &
Sutherland, 2004), it is slightly better than the life expectancies of individuals with
psychiatric disorders as established by Lawrence et al. (2013).
Rather than investigating the impact of psychiatric illnesses on physical
conditions, Von Korff et al. (2005) examined the impact of physical conditions on mental
4

health in a sample of 5,692 American adults. Their sample included individuals with
chronic spinal pain, other chronic pain conditions including arthritis, rheumatism, severe
headaches, and migraine, chronic physical conditions such as respiratory conditions (e.g.,
asthma, tuberculosis), digestive conditions, (e.g., irritable bowel syndrome, ulcer),
cardiovascular conditions (e.g., high blood pressure, heart disease, heart attack, stroke),
diabetes, cancer, epilepsy, and hearing or vision impairment, and mental disorders based
on DSM-IV diagnostic criteria including mood disorders (e.g., depression, dysthymia,
bipolar disorder I or II), anxiety disorders (e.g., panic disorder, agoraphobia, specific
phobia, social anxiety disorder, generalized anxiety disorder, posttraumatic stress
disorder), and substance use disorders (e.g., alcohol abuse and dependence, drug abuse
and dependence). Results demonstrated that US adults with chronic spinal pain also
typically experience comorbid chronic pain conditions, as well as chronic physical
illnesses or mental disorders. In fact, 68.6% of all individuals with chronic spinal pain
had another chronic pain condition, while 55.3% had at least one comorbid chronic
physical disorder, 35.0% had a comorbid mental disorder, and 87.1% had at least one of
these three possible comorbid conditions.
Aside from mental illness in and of itself, psychotropic medications often
prescribed as part of mental health treatment have been also identified as contributors to
various physical illnesses, particularly to cardiometabolic disorders. For instance, it is
common that patients receiving treatment with atypical antipsychotics (e.g., clozapine,
olanzapine, risperidone) experience weight gain, which can have adverse effects on
cardiovascular health. As atypical antipsychotics may have direct effects on glucose
5

metabolism, these medications have been connected to the development of type II
diabetes (Sussman, 2003). Later research conducted by Saddichha, Manjunatha, Ameen,
and Akhtar (2008) corroborated these findings with both typical and atypical
antipsychotics within 6 weeks of treatment. Saddichha et al.’s (2008) results also imply
that patients with schizophrenia, particularly male patients, may be more susceptible to
glycemic abnormalities prior to beginning antipsychotic treatment. Male patients gained a
mean 8.2 mg/dl and 21.5mg/dl in glucose profiles by type of bloodwork (fasting blood
sugar [FBS] and post-prandial blood sugar [PPBS], respectively), while female patients
gained a mean 3.2 (FBS) and 11.4 mg/dl (PPBS). This liability for future development of
diabetes has been suggested to be caused by dysfunction of the hypothalamic pituitary
adrenal (HPA) axis, which then leads to elevated cortisol levels and development of both
insulin resistance and diabetes (Ryan & Thakore, 2002).
Physical and mental health may also impact each other via other mediating
variables. First, poorer physical or mental health may lead to a decrease in wages and
productivity, which in turn limits access to healthier foods and environments. The
negative impact on income then has adverse consequences for mental or physical health;
for instance, low income, unemployment, and other socioeconomic deprivation, along
with risk factors such as alcohol misuse, smoking, high sugar intake, and physical
inactivity have been found to occur with comorbid physical and mental illnesses (Scott &
Happell, 2011; Wilton, 2004). Negative health outcomes may also be brought about by
poor sleep or stress associated with having a preexisting mental or physical health
condition (Contoyannis & Rice, 2001; Garcia-Gómez, Van Kippersluis, O’Donnell, &
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Van Doorslaer, 2013). Second, poor mental health may impair individuals’ decisionmaking capabilities, thus reducing their ability to obtain information concerning their
health, prevention, and quality of healthcare providers, and having unfavorable
implications for their physical health (Mani, Mullainathan, Shafir, & Zhao, 2013).
Third, physical and mental health are both linked to lifestyle choices, including
physical activity, alcohol and tobacco use, and diet (Ohrnberger, Fichera, & Sutton,
2017). Previous research has demonstrated that physical activity is negatively associated
with both anxiety and mood disorders as well as with poor physical health outcomes (De
Mello et al., 2013; Durstine, Gordon, Wang, & Luo, 2013; Gerber & Puehse, 2009;
Hegberg & Tone, 2015). There is also strong evidence that exercising has positive effects
on both mental and physical health outcomes for older adults (Clegg, Barber, Young,
Forster, & Iliffe, 2012), including those with dementia (Forbes et al., 2008). Additionally,
reverse-causality is likely to occur, as individuals who are of better physical and mental
health are also more likely to engage in physical activity (Ohrnberger et al., 2017).
Systematic research on smoking cessation and mental health has shown that depression,
anxiety, and stress decline after smoking cessation interventions are completed (Taylor et
al., 2014). A reverse-causal relationship is also likely, whereby rates of smoking are
twice as high among adults with depression or anxiety disorders than among adults
without them (Royal College of Physicians, Royal College of Psychiatrists [RCP], 2013,
as cited in Ohrnberger et al., 2017). Excessive alcohol use impacts health outcomes
negatively and is predicted by poorer physical and mental health (Frisher, Mendonça, &
Shelton, 2015; Rehm et al, 2010). Diet also has implications for health and well-being,
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with poor diet being associated with greater risk of mortality (Haveman-Nies, De Groot,
& Van Staveren, 2003).
Lastly, social interactions have great effects on health. Prior research has
determined that social interaction and mental health have a strong positive relationship
(Bekele et al., 2015; Dour et al., 2014). Steptoe, Shanker, Demakakos, and Wardle (2012)
found that loneliness and social isolation were associated with increased risk of mortality
when baseline mental and physical health were controlled across samples. Conversely,
systematic research has shown a constant effect of social relationships on decreased risk
of mortality. Reverse-causal relationships have also been established, such that physical
disability and poorer mental health led to greater isolation (Steptoe et al., 2012). Past
mental and physical health also have significant direct and indirect effects on present
physical and mental health. Ohrnberger et al. (2017) found that the indirect effects of past
mental health on current physical health are from current lifestyle choices and social
interactions, while the relationship of past physical health with present mental health is
mediated only by past physical activity.
Due to the bidirectional nature of the relationship between physical and mental
health, it stands to reason that treating one of these aspects should lead to improvements
in the other. Such an effect has been demonstrated by previous research. For example, a
study conducted by Lin et al. (2003) examined the effects of improving care for
depression on pain and functional outcomes in adults ages 60 years and older with both
depression and arthritis. This study indicated that older adults who received specialized
treatment for their depression (i.e., antidepressant medication and six to eight sessions of
8

psychotherapy) not only reported reductions in depressive symptoms at a 12-month
follow-up but also less interference in daily activities due to arthritis, less health-related
functional impairment, better health status, and higher overall quality of life than older
adults who did not receive the specialized depression treatment.
Personality’s Effects on Health and Illness
Personality can be defined as “an individual’s unique constellation of
psychological traits and states” (Cohen & Swerdlick, 1999, p. 381). The notion that
personality influences the development and course of physical illness has made several
appearances in various forms throughout the history and study of medicine (McMahon,
1976; Smith & Gallo, 2001). In the mid-to-late 20th century, this hypothesis was integral
in the emergence and development of such fields as behavioral medicine, health
psychology, and psychosomatic medicine; furthermore, it inspired a renewed interest in
personality research within the field of psychology (e.g., Contrada, Cather, & O’Leary,
1999; Stone, Cohen, & Adler, 1979; Surwit, Williams, & Shapiro, 1982; Weiss, Herd, &
Fox, 1981; Wiebe & Smith, 1997). Select topics in personality and health research, such
as Friedman and Rosenman’s (1959) account of the Type A personality/behavior pattern,
were so widely studied that they became relevant in popular culture. Other areas of focus,
for instance, implications of chronic negative affect for the development and progression
of disease, were initially met with criticism, but were later backed by more convincing
support (Friedman & Booth-Kewley, 1987; Suls & Bunde, 2005). Concepts such as
psychological hardiness were quite important in the rise of personality and health
research and are still viewed as influential despite declining in eminence as this area of
9

research became further developed. New topics introduced in personality theory, such as
conscientiousness, have also been identified as having potentially important impacts on
health (e.g., Friedman et al., 1993).
Several models have described the underlying mechanisms of the relationship
between personality and health (e.g., Cohen, 1979; Suls & Sanders, 1989; Wiebe &
Smith, 1997). Health behavior models indicate personality may influence daily healthrelated habits (e.g., smoking, exercise, diet) and other health behaviors (e.g., doctors’
visits, medical screening). Many health behaviors are associated with major domains of
personality, and these elements may mediate the relationship between personality and
subsequent illness. The interactional stress model cites physiological, rather than
behavioral, mechanisms that play a role in the association between personality and
disease. This model suggests that personality influences appraisals of both potentially
stressful life events and coping mechanisms. Appraisal and style of coping influence
physiological responses to stress (i.e., neuroendocrine responses, immune functioning
and inflammation, cardiovascular responses), which subsequently affect development of
disease (Schneiderman, Ironson, & Siegel, 2005).
Like the interactional stress model, the transactional stress model also describes
personality’s effects on appraisal, coping, and physiological response as a noteworthy
mechanism; however, this model lists an additional pathway in the process. In this model,
personality is viewed as an influence for exposure to potential stressors and stressreducing interpersonal resources, such as social support. By deciding to engage in certain
situations over others, unintentionally evoking reactions in others and intentionally
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affecting social situations, individuals can have impact on their interpersonal experiences
(Buss, 1987). Thus, personality can affect the frequency, magnitude, and duration of
exposure to daily stress as well as how readily available stress-reducing social resources
are to an individual (Smith & MacKenzie, 2006).
Constitutional predisposition models state that personality and health have noncausal associations between them. According to these models, genetic or other
constitutional factors are responsible for both physiological vulnerability to disease and
the behavioral, cognitive, and emotional phenotypes of personality. In this model, the
given personality characteristic and disease are otherwise unrelated co-effects of the
underlying cause. Lastly, the illness behavior model describes personality as influencing
perception of and attention to typical physiological sensations, labeling of these
sensations as symptoms of illness, reporting of these symptoms, and utilization of health
care; however, this model does not mention personality influencing actual disease
(Williams, 2004).
Despite these models of personality and health, the specific details of the
mechanisms or processes by which psychological factors produce physical distress are
not clearly defined. For instance, given the same amount of stress on internal organs or
damage to tissue, individuals vary in their subjective pain experiences. Some individuals
are able to accomplish great physical feats with apparent disregard or lack of notice to
any pain they may be experiencing, while others appear to overreact to even minor
physical pain. Personality factors are therefore important to consider when assessing
individuals’ reactions to physical injury or trauma, such as in medical or disability
11

evaluations (to be later discussed in greater detail). In the case of disability assessment,
for example, personality characteristics such as extreme dependency could sway an
individual toward seeking compensation following even a very minor physical injury
(Butcher & Harlow, 1987). Several specific personality characteristics have been
researched in this context, including conscientiousness, neuroticism, hostility,
interpersonal sensitivity, optimism, pessimism, and Type A and D personalities.
Conscientiousness.
Conscientiousness refers to the tendency to follow society’s behavioral norms, to
be task-and goal-oriented, to delay gratification, to develop and follow plans, and to
follow rules (John & Srivastava, 1999). With regard to health, conscientiousness has been
shown to predict greater health and longevity, as positive health behaviors and social
environmental factors tend to follow from being more conscientious (Roberts, Walton, &
Bogg, 2005). Conscientiousness has been linked to greater career success and earnings
(Judge, Higgins, Thoreson, & Barrick, 1999). Along with social responsibility,
conscientiousness has been linked to greater marital stability, which predicts longevity of
life (Cramer, 1993; Kelly & Conley, 1987; Tucker, Friedman, Wingard, & Schwartz,
1996; Tucker, Kressin, Spiro, & Ruscio, 1998). Conscientiousness is also positively
correlated with involvement in religion, which is associated with lower rates of substance
abuse and greater longevity (MacDonald, 2000; Taylor & MacDonald, 1999;
McCullough, Hoyt, Larson, Koenig, & Thoresen, 2000; Miller, Davis, & Greenwald,
2000).
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Aside from affecting health via social environmental factors, conscientiousness
also affects health and longevity through its relation to health behaviors. Poor healthrelated behaviors contribute to poor health outcomes, including cardiovascular disease
and cancer (McGinnis & Foege, 1993). In the United States, the most prominent
behavioral contributors to mortality are tobacco use, unhealthy diet, physical inactivity,
excessive use of alcohol, gun violence, risky sexual behavior, risky driving/automobile
accidents, and drug use (McGinnis & Foege, 1993). As these behaviors are related to
cardiovascular disease, cancer, AIDS, and accidental death, they are quite relevant to
health and longevity. Aspects of conscientiousness, particularly impulse control and
reliability, are negatively related to drug and alcohol abuse (Walton & Roberts, 2004).
Conscientiousness has also been demonstrated to be positively related to preventative and
accident control behaviors, including regular doctors’ visits and checking smoke alarms
around the home, and negatively related to risky behaviors, such as driving without a
seatbelt (Chuah, Drasgow, & Roberts, 2006).
A meta-analysis conducted by Roberts, Walton, and Bogg (2005) demonstrated
further support for these positions by comparing known relationships between
conscientiousness-related traits and nine negative health behaviors among the leading
correlates of mortality: alcohol use, disordered eating (including obesity), drug use,
physical inactivity, risky sexual behaviors, risky driving behaviors, tobacco use, suicide,
and violence (McGinnis & Foege, 1993). Conscientiousness negatively predicted each
behavior, with conventionality being the facet of conscientiousness demonstrating the
strongest and most consistent relationship with these behaviors. Individuals who
13

considered themselves to be more conventional in orientation, reflecting inclination
toward adherence to society’s norms, were much less likely to abuse drugs and alcohol,
drive in a risky manner, have an unhealthy diet, or lead an inactive lifestyle. Reliability
and impulse control were also consistently correlated with the selected behaviors, while
industriousness and orderliness had less consistent and relatively weak correlations with
these behaviors. Conscientiousness is a critical factor in predicting health in terms of
social environments and health behaviors. The factors implicated in conscientiousness
predicting longevity are the lifestyles conscientious individuals lead, as well as the
health-related activities and practices in which they participate. Conscientious individuals
create life contexts for themselves that enhance health and engage in activities that either
do not detract from health or promote it (Roberts et al., 2005).
Emotionality/neuroticism.
Emotionality (also referred to as neuroticism, and, more recently, negative
emotionality) and extraversion/introversion have been hypothesized to differentially
predispose individuals to the development of various mental illness symptoms (Eysenck,
1967; Gray, 1982). For instance, emotional introverts may experience symptoms of
depression and anxiety, while emotional extraverts may demonstrate hostility and
psychoticism (Claridge, 1985). A longitudinal study conducted by Levenson, Aldwin,
Bossé, and Spiro (1988) provided support for these positions by demonstrating that
emotionality accounted for a majority of the variance in psychological symptoms
reported by a subsample of 1,324 men from the Boston Veterans Administration’s
Normative Aging Study (NAS) across a span of ten years. Individuals higher in
14

emotionality (as assessed by a short version of the Eysenck Personality Inventory [EPI;
Eysenck & Eysenck, 1968]) reported more psychological symptoms on the revised
version of the Hopkins Symptom Checklist (SCL-90-R; Derogatis, 1983), including
depression, anxiety, paranoid ideation, somatization, hostility, and psychoticism, than
individuals lower in emotionality.
Hostility.
Chronic anger and hostility have long been thought to have negative implications
for physical health (Siegman, 1994). Specifically, hostility has been found to be an
important risk factor for coronary heart disease (CHD), as well as all-cause mortality
(Booth-Kewley & Friedman, 1987; Matthews, 1988; Smith, 1992). Hostility may also be
related to negative health behaviors associated with poor physical health, such as
smoking, excessive alcohol intake, driving while drinking alcohol, greater caffeine
consumption, greater fat and caloric intake, lower physical activity, greater body mass,
higher blood pressure, sleep problems, and nonadherence to medication or medical
regimens (e.g., Almada et al., 1991; Barefoot, Dahlstrom, & Williams, 1983; Houston &
Vavak, 1991; Koskenvuo et al., 1988; Lee, Mendes de Leon, & Markides, 1988; Leiker
& Hailey, 1988; Lipkus, Barefoot, Williams, & Siegler, 1994; Musante, Treiber, Davis,
Strong, & Levy, 1992; Romanov et al., 1994; Scherwitz et al., 1992; Shekelle, Gale,
Ostfeld, & Paul, 1983; Siegler, Peterson, Barefoot, & Williams, 1992). Therefore,
negative health behaviors may be a link between hostility and subsequent CHD (Leiker &
Hailey, 1988; Siegler, 1994). If these risk factors for disease mediate the relationship
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between hostility and health, the relationship may weaken if these risk factors were
controlled (Miller, Smith, Turner, Guijarro, & Hallet, 1996).
Demographic characteristics such as sex, age, socioeconomic status, and
race/ethnicity could also influence the strength of the association between hostility and
physical health. For instance, hostility and CHD are both related to sex, age, social status,
non-Caucasian ethnicity, marital status, occupation, and income (Barefoot, Beckham,
Haney, Siegler, & Lipkus, 1993; Barefoot et al., 1991; Carmelli et al., 1991; Koskenvuo
et al., 1988; Romanov et al., 1994; Scherwits, Perkins, Chesney, & Hughes, 1991;
Scherwitz et al., 1992; Shekelle et al, 1983; Siegler, Peterson, Barefoot, & Williams,
1992; Smith & Frohm, 1985). Differences in these demographic characteristic among
samples may also account for variations in the findings of research on hostility and CHD.
For instance, Williams, Nieto, Sanford, Couper, and Tyroler (2002) found high trait anger
was associated with increased risk of stroke among participants aged 60 years or younger,
even when biomedical, demographic, and behavioral risk factors were controlled for.
Furthermore, effects of this study were similar across sex and ethnicity. A study of
approximately 13,000 White and Black men and women found that higher scores on the
Spielberger et al. (1985) trait anger scale were associated with a 50-75% increased risk of
CHD over a four-and-a-half-year follow-up (Williams et al., 2000). This association was
found even when behavioral, biomedical, and demographic risk factors were controlled
for. Results of similar research, however, have been mixed. For example, self-reported
hostility in a sample of over 9,000 initially healthy French and Irish men was not
associated with CHD over a span of 5 years (Sykes et al., 2002). Other studies have
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indicated that anger and hostility are not associated with morbidity or mortality among
CHD patients (Kaufmann et al., 1999; Welin, Lapas, & Wilhelmsen, 2000). However,
one study of approximately 800 women with CHD revealed that those in the uppermost
quartile of Cook and Medley’s (1954) Hostility (Ho) scale scores were twice as likely to
experience a recurrent myocardial infarction than women with low Ho scores after
controlling for biomedical, behavioral, and demographic variables (Chaput et al., 2002).
Hostility’s association with various interpersonal styles is also linked to health.
For instance, verbal aggressiveness and outward anger are associated with hostile
dominance. These traits might then influence health by “moving against” people.
Individuals who demonstrate hostile dominance exhibit an adversarial, controlling style
of interacting with others. They are likely to attempt to influence others, which in turn
prompts resistance (Smith, Glazer, Ruiz, & Gallo, 2004). These efforts to influence and
control others cause increases in blood pressure and heart rate, and this physiological
reactivity may contribute to cardiovascular disease (Manuck, Marsland, Kaplan,
&Williams; 1995; Smith, Allred, Morrison, & Carlson, 1989; Smith, Ruiz, & Uchino,
2000; Treiber et al., 2003). Alternatively, hostile submissiveness involving hostility and
internalized anger suggests a “moving away” interpersonal style in which less confident
and assertive people might be vigilant against potential harm. This mistrust may in turn
lead to decreased social support (Smith et al., 2004). Both vigilance and low social
support have also been associated with increased cardiovascular reactivity (Kamarck,
Peterman, & Raynor, 1998; Lepore, 1998; Smith et al., 2000).
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Interpersonally sensitivity.
Interpersonal sensitivity (IS) is characterized by ongoing concerns regarding
negative social evaluation. Other related constructs, including introversion, sensitivity to
rejection, social inhibition, social anxiety, and submissiveness subsume aspects of IS. In
regard to health, IS individuals are at an increased risk for development of infectious
diseases, such as progression of human immunodeficiency virus (HIV), incidence of
pneumonia and bronchitis, and incidence of colds following inoculation with a virus. It is
possible these individuals are also at greater risk for developing CVD; however, IS is not
implicated in cancer morbidity and mortality. Additionally, while IS temporally precedes
the development of disease, potential confounds hinder achieving certainty of conclusion
as to whether IS has an effect on mortality and morbidity. The effects of introversion as
an aspect of IS are particularly accentuated in relation to health, and may only be evident
in contexts which activate concerns of social evaluation (e.g., living with the stigma
surrounding HIV) (Marin & Miller, 2013).
Optimism and pessimism.
Optimism, or the tendency to maintain a positive outlook on the future, rather than
pessimistic or hopeless beliefs, has been linked with several favorable health outcomes
(Smith & MacKenzie, 2006). Three conceptual models of optimism are utilized in
personality and health research. The most widely used model is Scheier and Carver’s
(1985) generalized expectancy model, which defines optimism as the tendency to expect
positive future experiences. A short self-report scale, such as the Life Orientation Test, is
then used to measure this construct. Seligman and colleagues’ explanatory style approach
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defines optimism as a tendency to attribute life difficulties to “temporary, specific, and
external (as opposed to permanent, pervasive, and internal) causes” (Gillham, Shatte,
Reivich, & Seligman, 2001, p. 54). Measures of this construct include self-report scales
and expert coding of written or verbal material.
Previous research has found optimism (as assessed by the Life Orientation Test)
to be linked with a lower incidence of medical complications following coronary artery
bypass surgery and angioplasty, as well as decreased progression of atherosclerosis
(Helgeson & Fritz, 1999; Matthews, Raikkonen, Sutton-Tyrrell, & Kuller, 2004; Scheier
et al., 1989; 1999). Pessimism has been found to be associated with decreased survival in
women with breast cancer; however, optimism was not determined to play a role in
survival in this population (Schulz, Bookwala, Knapp, Scheier, & Williamson, 1996).
Prospective studies have demonstrated that content ratings of optimistic explanatory style
have been linked to better physician-rated health and greater longevity of life (Peterson,
Seligman, & Vaillant, 1988; Peterson, Seligman, Yurko, Martin, & Friedman, 1998).
Additional optimism measures have been related to longevity, lower incidence of CHD,
and increased longevity following stroke (Kubzansky, Sparrow, Vokonas, & Kawachi,
2001; Lewis, Dennis, O’Rourke, & Sharpe, 2001; Maruta, Colligan, Malinchoc, &
Offord, 2000). Greater optimism and/or lower pessimism have been linked to better
immune functioning and lower ambulatory blood pressure (Raikkonen, Matthews, Flory,
Owens, & Gump, 1999; Segerstrom, Taylor, Kemeny, & Fahey, 1998). Optimism is also
associated with greater participation in healthcare (Lin & Peterson, 1990; Strack, Carver,
& Blaney, 1987). Lastly, meta-analytic research strongly suggests that optimism
19

significantly predicts physical health and plays a positive role in physical well-being
(Rasmussen, Scheier, & Greenhouse, 2009). In contrast, hopelessness has been associated
with the development of hypertension, greater incidence of cardiovascular disease- and
cancer-related death, incidence of myocardial infarction, further progression of
atherosclerosis, and decreased longevity of life (Anda et al., 1993; Everson et al., 1996;
Everson, Kaplan, Goldberg, & Salonen, 2000; Everson, Kaplan, Goldberg, Salonen &
Salonen 1997; Stern, Dhanda, & Hazuda, 2001).
Associations between optimism and other characteristics, such as coping style,
have also been linked to greater physical health. For instance, problem-focused coping, or
attempting to deal with sources of stress, is more likely to be utilized in situations for
which positive change is possible. Problem-focused coping may also be more likely
among individuals who expect positive change to occur. Indeed, optimism has been
found to be positively correlated with the use of problem-focused coping, particularly if
individuals perceived their stressful situations to be somewhat controllable. Emotionfocused coping, or attempting to reduce or eradicate emotional distress associated with or
brought on by stressful situations, however, has demonstrated mixed results in relation to
optimism, due to various subclasses of this coping style. Specifically, optimism was
found to be positively correlated with utilization of positive reinterpretation, and was
negatively correlated with denial/distancing. Among individuals who perceived their
situations to be uncontrollable, optimism was also positively associated with accepting
the reality of the situation. This tendency in particular likely facilitates adjustment to
various life difficulties such as terminal illness or chronic physical impairment (Scheier
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& Carver, 1987). For example, Schulz and Decker (1985) determined a patient’s ability
to accept his or her disability was one of the most important predictors of positive longterm psychological adjustment among a group of patients with spinal cord injuries.
The health habits of optimistic individuals may also be related to their health
outcomes. The extent of similarity between stressful situations involving illness or injury
and other stressful situations suggests, based on the previously discussed coping styles,
that optimistic individuals handle these stressors more adaptively. In the context of
illness, this tendency to cope adaptively should translate into engaging in more adaptive
health behaviors, such as following a prescribed medicine regimen or making behavior
changes to decrease the severity of illness. Similarly, to the extent that positive health
habits are viewed as being adaptive, optimists should be likely to believe that they will
benefit from them (Scheier & Carver, 1987).
Physiological mechanisms may also be associated with the level of physical wellbeing attained by optimists. Research conducted by Van Treuren and Hull (1986)
suggests that cardiovascular reactivity to stress may underlie better health outcomes often
experienced by optimistic individuals. Several significant results emerged from this
study, the first of which was a significant interaction between optimism and time of
measurement of systolic blood pressure (SBP). Optimistic participants exhibited
decreases in SBP over time, while pessimists’ SBP increased from pretest to posttest,
then decreased from posttest to recovery. A significant interaction for diastolic blood
pressure (DBP) was also found, such that DBP tended to decrease over time for
optimistic participants who received success feedback on their tasks. Optimistic
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participants who did not receive success feedback and all pessimistic participants
demonstrated an increase in DBP between pretest and posttest measurement, and a
decline in DBP from posttest measurement to recovery. Lastly, pulse rate was found to
have a similar significant interaction. Optimistic participants given success feedback
showed a general decrease in pulse rate over time, while all other participants
demonstrated an initial increase followed by a decrease. This data thus supports the
notion that optimists experience lesser cardiovascular response to stress than pessimists
do, which may subsequently encourage more positive health outcomes (Scheier &
Carver, 1987).
Aside from cardiovascular response, optimism may also be related to immune
system functioning, although a direct establishment of this link has not yet been made.
Speculation of this relationship, however, relies on two concepts. First, immunological
functioning has been found to be associated with depression. Previous research has
examined the relationship between DNA repair in lymphocytes and depression among a
sample of nonmedicated, nonpsychotic inpatient psychiatric patients. DNA repair in
patients who were depressed was inferior to that of patients who were not depressed
(Kiecolt-Glaser, Stephens, Lipetz, Speicher, & Glaser, 1985). Secondly, the association
between dispositional optimism and the development of depressive symptomatology has
also been observed. A study focused on postpartum depression assessed depressive
symptoms just prior to the stressful event’s (i.e., childbirth) onset, and symptoms were
later measured a second time. Optimism was found to have an inverse relationship with
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depression, both prior to the stress of childbirth, and across time (Carver & Gaines,
1987).
Type A personality.
Like hostility and chronic anger, the Type A personality or Type A behavior
pattern (TABP) has been linked to the development of CHD. The definition of the Type
A person/style/behavior pattern varies, ranging from workaholism to aggression to a
specific expressive and emotional style (Friedman & Booth-Kewley, 1987). Several
behaviors typical of a Type A individual are also demonstrated by so-called “coronaryprone” individuals, including loud, explosive speech, fast talking, and hurrying.
Additionally, these behaviors are generally viewed as indicative of underlying unhealthy
emotional states. These emotional states typically consist of feelings of tension,
competitiveness, and even hostility, which may stem from insufficient coping skills
exhibited by Type A individuals. The characteristic Type A behaviors, therefore,
represent the individual’s desire to assert and maintain control over his or her
environment (Glass, 1977; 1981).
Type A personality/behavior appears to negatively impact health only when
presented in the typical pattern described above (i.e., “true Type As”) (Friedman &
Booth-Kewley, 1987, p. 784). For instance, people who display characteristics such as
being active, ambitious, and hard-working, or behaviors such as loud, rapid speech, may
be classified as Type A because these characteristics and actions are typical of true Type
A personality and behavior. In such individuals, however, these qualities and behaviors
may be indicative of alertness and vigor rather than true Type A behavior. Furthermore,
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many hard-working individuals, while classified as Type A, cope well and have good
health. Their personalities may be labeled as “hardy” or “coherent,” and they possess
such characteristics as internal locus of control and lack of self-alienation, which can
have protective effects for health (Antonovsky, 1979; Friedman & Booth-Kewley, 1987;
Kobasa, 1979; Kobasa, Maddi, & Kahn, 1982). On the other hand, some individuals
labeled Type B (i.e., quiet, inactive, and not emotionally expressive) may be prone to
CHD due to a tendency to repress hostility and ambition. Their proneness to CHD may
go undetected because they are quiet, slow to speak, and unaggressive on the surface
(Friedman, Hall, & Harris, 1985).
Type D personality.
The Type D personality, or “distressed” personality type, refers to individuals
who simultaneously exhibit negative affectivity (NA) and social inhibition (SI). It is
suggested the Type D individual experiences negative emotions and inhibits his or her
expression in social interactions, thereby proposing that NA along with the individual’s
style of coping with negative emotions (i.e., inhibition of expressing negative emotions in
social interactions) can be considered risk factors for poor health (Williams et al., 2008).
Specifically, previous research has shown that Type D personality is linked to CVD and
CHD, as well as unhealthy behaviors (Williams et al., 2008). Type D personality has
been found to be associated with a decreased likelihood of seeking and receiving
appropriate medical care (e.g., regular medical check-ups), as well as an unhealthy
lifestyle. Type D individuals are more likely to maintain an unhealthy diet and/or smoke,
and are less likely to spend time outdoors than non-Type D individuals (Pedersen et al.,
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2004; Williams et al., 2008). Individuals with Type D personality within the general
population also generally report more somatic complaints and significantly lower health
status than their non-Type D counterparts (De Fruyt & Denollet, 2002; Jellesma, 2008).
Specifically, De Fruyt and Denollet (2002) found that Type D individuals reported
greater somatic distress, anxiety, and depression than non-Type D individuals, and
Jellesma (2008) determined the combination of social inhibition and negative affect,
which makes up the Type D personality, denotes an elevated risk for self-reported
somatic complaints in adolescents.
As Type D personality has been previously found to be associated with various
cardiovascular conditions, a great deal of research has focused specifically on the effects
of Type D personality on heart patients’ health. For patients with heart failure, Type D
personality was found to independently predict impaired health status and greater cardiac
symptoms (Schiffer, Denollet, Widdershoven, Hendriks, & Smith, 2007; Schiffer,
Pedersen, Widdershoven, & Denollet, 2008). These patients were also six times more
likely to report impaired health status than a reference group of non-Type D heart failure
patients (Pelle, Schiffer, Smith, Widdershoven, & Denollet, 2009). Like Type D
individuals in the general population, Type D heart failure patients also demonstrate less
likelihood of seeking appropriate medical care, leading to significant declines in health
status among these patients (Williams et al., 2008). Type D personality has been
confirmed to be independently associated with indicators of cardiovascular reactivity,
such as reduced heart rate recovery (von Kanel et al., 2009). This personality style has
additionally been associated with increased levels of cortisol, increased oxidative stress,
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immune system dysfunction, and decreased counts of bone marrow endothelial pronator
cells in cardiac patients (Kupper, Gidron, Winter, & Denollet, 2009; Molloy, PerkinsPorras, Strike, & Steptoe, 2008; Van Craenenbroeck et al., 2009).
The presence of Type D personality also has adverse effects on mental health.
Several studies have demonstrated that individuals from the general population with Type
D personality experienced greater distress and more symptoms of depression and anxiety
than non-Type D individuals (e.g., De Fruyt & Denollet, 2002; Jellesma, 2008; Pedersen,
Schiffer, Smith, Widdershoven, & Dennolet, 2009; Polman, Borkoles, & Nicholls, 2009;
Van Hiel & De Ciercq, 2009; Williams, O’Carrol, & O’Connor, 2008). Similar results
have also been observed in various medical populations. For instance, a study conducted
by Schiffer et al. (2005) found that Type D personality chronic heart failure (CHF)
patients were more likely to have worse health, more depressive symptoms, and
decreased mood status as compared to their non-Type D counterparts. In a separate study
of patients with acute coronary syndromes (ACS), Type D personality was found to be a
predictor of decreased quality of life at 5-year follow-up (Denollet, Vaes, & Brutsaert,
2000). Type D personality has also been related to difficult medical outcome in ACS
patients (e.g., Denollet & Brutsaert, 1998; Denollet et al., 1996; Denollet et al., 2000).
Similarly, arrhythmia patients with Type D personality undergoing implantable
cardioverter defibrillator (ICD) therapy experienced greater anxiety and symptoms of
depression than non-Type D patients receiving the same treatment (Pedersen, van
Domburg, Theuns, Jordaens, & Erdman, 2004). Additionally, people with a Type D
personality have been found to report mental health disorders and lower levels of social
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support more frequently than non-Type D individuals (Oginska-Bulik, 2006; Williams et
al., 2008).
Personality Assessment
In the field of clinical psychology, psychological assessment is ranked highly in
terms of professional importance (Greenberg, Smith, & Muenzen, 1995; Phelps, Eisman,
& Kohout, 1998). Unlike psychotherapy, formal assessment is unique to the practice of
psychology relative to services rendered by other health care providers. Psychological
assessment serves several purposes, including describing patients’ current functioning
(e.g., cognitive abilities, severity of disturbance), confirming, refuting, or modifying
clinical impressions derived from less structured interactions with patients, and
identifying therapeutic needs. Additionally, assessment can highlight issues likely to arise
in treatment, recommend mode of intervention, offer insight into probable treatment
outcomes, and aid in differential diagnosis of emotional, behavioral, and cognitive
disorders. Formal assessment can also assist in monitoring treatment over time to
evaluate the efficacy of interventions or to identify new concerns that may need attending
to after original presenting complaints are resolved. Finally, psychological assessment
assists in managing risk, including minimizing potential legal liabilities and identifying
adverse reactions to treatment, and allows for provision of assessment feedback as its
own therapeutic intervention (Meyer et al., 2001).
Personality assessment in psychology can be used in the diagnosis of mental
illnesses, as a means of predicting future behavior, as a measure of unconscious
processes, and as a quantification of interpersonal styles and tendencies (Smith & Archer,
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2008). Anastasi (1988) provides a more general and all-encompassing definition of
personality assessment as being “an objective and standardized measure of a sample of
behavior” (p. 22). A second, broader definition of personality assessment, given by Rorer
(1990), is as follows: “the description of people…a person’s manner of behaving, his or
her moods, and the situations and behaviors he or she chooses as opposed to the ones he
or she avoids” (p. 693). Additionally, while personality assessment is utilized in many
different settings, there are five primary reasons to conduct such assessment (Meyer et
al., 2001). First, personality assessment can aid in describing psychopathology as well as
in differential diagnosis. Psychological tests are based on norms, which provide a starting
point for interpretation. Standardized test administration processes also assist in
generating diagnostic data that is typically more predictive and informative than data
gathered in a clinical interview. Second, personality assessment can describe and predict
an individual’s everyday behavior such as the quality of his or her interactions with
others, his or her expectations of relationships, personal strengths and weaknesses, and
typical methods of coping with stress. Third, personality assessment can inform
psychological treatment such as offering insight into which psychotherapy modality or
medication might be most effective for a given individual. Similarly, personality
assessment can aid in monitoring treatment. Assessment results may serve as a baseline
measure of an individual’s functioning with changes reflected in period retesting, as with
the Beck Depression Inventory (BDI; Beck & Steer, 1987). Finally, personality
assessment itself can be a form of treatment. The Therapeutic Assessment (TA; Finn,
1996) model was designed to increase the efficacy of personality assessment and
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feedback as therapeutic activities. The Therapeutic Assessment model’s roots are in self
and humanistic psychology, as well as the work of Fischer (1994, 2000), and it views
assessment as a collaboration in which the client and examiner work together to gain
further understanding regarding the client’s personality, interpersonal dynamics, and
present problems (Smith & Archer, 2008).
Psychological testing is the most reliable and valid component of the broader
psychological assessment, which involves compiling data from several sources (e.g.,
multiple assessment methods, tests, historical and referral information, and behavioral
observations) in order to form a cohesive and complete understanding of the individual
being evaluated (Handler & Meyer, 1998). Psychological tests are samples of behaviors
measured under standardized conditions and then scored and interpreted based on norms
(Murphy & Davidshofer, 2005). Personality assessment is the measurement of
psychological traits, states, values, interests, attitudes, worldviews, cognitive, emotional,
and behavioral styles, personal identity, and related individual characteristics (Cohen &
Swerdlik, 1999).
Methods of personality assessment.
As there are nearly limitless reasons a client might undergo personality
assessment, there are several forms of tests available for this purpose. Traditionally,
personality tests have been placed into one of two categories: projective and objective
tests. However, the field of personality assessment has proposed new, more accurate
terminology to replace these labels: performance-based and self-report, respectively.
These two categories alone may not suffice, as testing has become increasingly advanced;
29

for example, the category of behavioral assessment does not fit neatly into either
classification.
Traditionally, projective/performance-based tests have typically been unstructured
in their response formatting, allowing respondents to respond as much or as little as they
choose (within certain guidelines) to the particular test stimulus. The mindset behind
performance-based measures is that the lesser amount of structure provided by these
measures allows for important individual characteristics to be displayed in such a way
that they can be coded and interpreted by clinicians. While performance-based measures
share the common feature of being relatively unstructured, they differ in substantive ways
(Smith & Archer, 2008). Some measures, such as the Rorschach Inkblot Test (Exner,
2003), have a standardized test administration process, response format, and scoring.
Other performance-based measures, like the Thematic Apperception Test (TAT), are not
as well-standardized, or have standardized procedures that are not widely accepted and
used (e.g., in the case of the TAT, Cramer, 1996; Morgan & Murray, 1935; Murray,
1943; Westen, 1995, Westen, Lohr, Silk, Kerber, & Goodrich, 2002).
In contrast to performance-based measures, self-report measures ask respondents
to answer a series of questions about themselves. The response format and question style
of the test depends on its purpose and the construct being measured. For instance, selfreport measures may be comprised of paper-and-pencil questionnaires or structured
interviews conducted by trained clinicians. Self-report measures generally fall into one of
two categories: omnibus or narrow-band. Omnibus measures assess several domains of
personality, psychopathology, or functioning. One example of an omnibus, or broad30

band, measure is the Personality Assessment Inventory (PAI; Morey, 1991). The PAI
assesses several constructs including depression, anxiety, personality features,
interpersonal expectations, and thought disorder, among others. In contrast, the
previously mentioned BDI (Beck & Steer, 1987) is a narrow-band measure, as it
exclusively assesses depression. Omnibus measures generally allow for broad screening
of various characteristics and psychopathology, while narrow-band measures are
typically better suited to measure one or a few select characteristics in greater detail
(Smith & Archer, 2008).
Popular broad-band personality assessment measures.
Of the omnibus/broad-band personality measures, the most widely used are the
Minnesota Multiphasic Personality Inventory-2 (MMPI-2; Butcher, Dahlstrom, Graham,
Tellegen, & Kaemmer, 1989; Butcher et al, 2001; to be later discussed in greater detail),
the PAI, the Millon Clinical Multiaxial Inventory-IV (MCMI-IV; Millon, Grossman, &
Millon, 2015), and the NEO Personality Inventory-3 (NEO-PI-3; McCrae & Costa,
2010).
The PAI assesses the major dimensions of psychopathology found in all clinical
disorders and select personality disorders according to the DSM-IV-TR (American
Psychological Association, 2000). The PAI’s 344 items are divided into 22 nonoverlapping full scales: four validity scales, eleven clinical scales, five treatment
considerations scales, and two interpersonal scales. These items are responded to via a
four-alternative scale, with the options of totally false, slightly true, mainly true, and very
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true. Additionally, nine of the eleven clinical scales and one treatment consideration scale
have three to four subscales each (Morey, 1991).
Similar to the MMPI instruments, the PAI has a set of validity scales that measure
Inconsistency (ICN; poor concentration or inattention), Infrequency (INF; idiosyncrasy in
or random responding), Negative Impression Management (NIM; negative response set
caused by pessimistic mindset and/or intentional dissimulation), and Positive Impression
Management (PIM; positive response set due to naïveté or intentional dissimulation). The
eleven PAI clinical scales are: Somatic Complaints (SOM), Anxiety (ANX), Anxiety
Related Disorders (ARD), Depression (DEP), Mania (MAN), Paranoia (PAR),
Schizophrenia (SCZ), Borderline Features (BOR), Antisocial Features (ANT), Alcohol
Problems (ALC), and Drug Problems (DRG). As mentioned previously, the majority of
the PAI clinical scales have their own subscales. The SOM subscales include Conversion
(SOM-C), Somatization (SOM-S), and Health Concerns (SOM-H). ANX and DEP can be
assessed in terms of Cognitive (ANX-C; DEP-C), Affective (ANX-A; DEP-A), and
Physiological (ANX-P; DEP-P) symptoms. ARD’s subscales are Obsessive-Compulsive
(ARD-O), Phobias (ARD-P), and Traumatic Stress (ARD-T). Those for MAN are Activity
Level (MAN-A), Grandiosity (MAN-G), and Irritability (MAN-I). The PAR subscales
include Hypervigilance (PAR-H), Persecution (PAR-P), and Resentment (PAR-R), while
those for SCZ are Psychotic Experiences (SCZ-P), Social Detachment (SCZ-S), and
Thought Disorder (SCZ-T). BOR’s subscales are Affective Instability (BOR-A), Identity
Problems (BOR-I), Negative Relationships (BOR-N), and Self-Harm (BOR-S). Lastly, the
ANT subscales are Antisocial Behaviors (ANT-B), Egocentricity (ANT-E), and Stimulus
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Seeking (ANT-S). The five treatment consideration scales are Aggression (AGG), Suicidal
Ideation (SUI), Stress, (STR), Nonsupport (NON), and Treatment Rejection (RXR). Of
these five, only AGG has subscales, which are as follows: Aggressive Attitude (AGG-A),
Verbal Aggression (AGG-V), and Physical Aggression (AGG-P). Lastly, the two
interpersonal scales are Dominance (DOM) and Warmth (WRM) (Morey, 1991).
The MCMI-IV is a 195-item questionnaire that measures major dimensions of
psychopathology found in personality disorders (PDs) and more severe psychiatric
syndromes (Craig, 2008). The MCMI-IV items are responded to in true/false format, and
are divided into 28 scales including four validity (modifier) scales, twelve personality
style scales, three severe personality style scales, seven clinical syndrome scales, and
three severe clinical syndrome scales (Millon et al., 2015). The validity scales are
referred to as “modifying indices” because they modify (i.e., raise or lower) scores on the
other scales based on their values’ magnitude (Craig, 2008). These scales include the
Validity (V), Disclosure (X), Desirability (Y), and Debasement (Z) indices. The
Personality Styles scales are composed of the Schizoid (1), Avoidant (2A), Melancholic
(2B), Dependent (3), Histrionic (4A), Turbulent (4B), Narcissistic (5), Antisocial (6A),
Sadistic (6B), Compulsive (7), Negativistic (8A), and Masochistic (8B) scales. Severe
Personality Styles scales include Schizotypal (S), Borderline (C), and Paranoid (P). The
Clinical Syndromes scales are Generalized Anxiety (A), Somatic Symptom (H), Bipolar
Spectrum (N), Persistent Depression (D), Alcohol Use (B), Drug Use (T), and PostTraumatic Stress (R). Lastly, the Severe Clinical Syndromes scales are comprised of
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Schizophrenic Spectrum (SS), Major Depression (CC), and Delusional (PP) (Millon et
al., 2015).
The addition of the MCMI-IV Grossman Facet scales is intended to clarify further
distinctions from the primary personality scales. Each Clinical Personality Pattern scale
(scales 1 through 8B) and Severe Personality Pattern scale (scales S, C, and P) has three
facet scales related to its structural and functional domains. The Facet scales for scale 1
include Interpersonally Unengaged (1.1), Meager Content (1.2), and Temperamentally
Apathetic (1.3). Scale 2A’s Facet scales are Interpersonally Aversive (2A.1), Alienated
Self-Image (2A.2), and Vexatious Content (2A.3), while those of scale 2B are Cognitively
Fatalistic (2B.1), Worthless Self-Image (2B.2), and Temperamentally Woeful (2B.3). The
Facet scales for scale 3 are Expressively Puerile (3.1), Interpersonally Submissive (3.2),
and Inept Self-Image (3.3). The scale 4A Facet scales are Expressively Dramatic (4A.1),
Interpersonally Attention-Seeking (4A.2), and Temperamentally Fickle (4A.3), while the
scale 4B Facet scales include Expressively Impetuous (4B.1), Interpersonally HighSpirited (4B.2), and Exalted Self-Image (4B.3). Scale 5’s Facet scales are Interpersonally
Exploitive (5.1), Cognitively Expansive (5.2), and Admirable Self-Image (5.3). The Facet
scales of scale 6A are Interpersonally Irresponsible 6A.1), Autonomous Self-Image
(6A.2), and Acting-Out Dynamics (6A.3), while the scale 6B Facet scales are
Expressively Precipitate (6B.1), Interpersonally Abrasive (6B.2), and Eruptive
Architecture (6B.3). Scale 7’s Facet scales include Expressively Disciplined (7.1),
Cognitively Constricted (7.2), and Reliable Self-Image (7.3). The Facet scales of scale 8A
are Expressively Embittered (8A.1), Discontented Self-Image (8A.2), and
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Temperamentally Irritable (8A.3), and those of scale 8B are Undeserving Self-Image
(8B.1), Inverted Architecture (8B.2), and Temperamentally Dysphoric (8B.3). Lastly, the
Facet scales of scales S, C, and P are Cognitively Circumstantial (S.1), Estranged SelfImage (S.2), and Chaotic Content (S.3), Uncertain Self-Image (C.1), Split Architecture
(C.2), and Temperamentally Labile (C.3), and Expressively Defensive (P.1), Cognitively
Mistrustful (P.2), and Projection Dynamics (P.3), respectively.
The NEO-PI-3 (McCrae & Costa, 2010) is a 240-item measure that assesses five
broad personality dimensions. Test takers respond to each item on a five-point scale
ranging from strongly disagree to strongly agree. Three of these domain scales,
Neuroticism (N), Extraversion (E), and Openness to Experience (O), have long been
researched and serve as the basis for this Inventory’s original name, NEO. The NEO PI,
NEO PI-R, and NEO PI-3 also measure two additional dimensions, Agreeableness (A)
and Conscientiousness (C). Also included on the NEO PI-3 are six facets on which each
of these five domains can be scored. The facets for N are Anxiety (N1), Angry Hostility
(N2), Depression (N3), Self-Consciousness (N4), Impulsiveness (N5), and Vulnerability
(N6). Those for E include Warmth (E1), Gregariousness (E2), Assertiveness (E3),
Activity (E4), Excitement-Seeking (E5), and Positive Emotions (E6). The O facets are
Fantasy (O1), Aesthetics (O2), Feelings (O3), Actions (O4), Ideas (O5), and Values (O6).
A’s facets are Trust (A1), Straightforwardness (A2), Altruism (A3), Compliance (A4),
Modesty (A5), and Tender-Mindedness (A6). Lastly, the C facets include Competence
(C1), Order (C2), Dutifulness (C3), Achievement Striving (C4), Self-Discipline (C5), and
Deliberation (C6).
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The MMPI instruments, including the MMPI, MMPI-2, MMPI-A, and MMPI-2
Restructured Form (MMPI-2-RF) are the most widely used clinical personality
inventories worldwide (Butcher, 2010; Friedman, Lewak, Nichols, & Webb, 2001;
Greene, 2011; Lubin, Larsen, & Matarazzo, 1984; Lubin, Larsen, Matarazzo, & Seever,
1985). Since its development and release, the MMPI has been quite popular, and has been
consistently ranked as one of the top personality instruments (Butcher, 2010; Freidman,
Webb, & Lewak, 1989). The MMPI, MMPI-2, and MMPI-2-RF, designed for assessing
adults, are discussed in greater detail below.
MMPI.
The original MMPI (Hathaway & McKinley, 1943) was comprised of 566
numbered statements, which could be answered True or False or, in the form of a card
deck, sorted into True, False, or Cannot Say categories (Friedman, Bolinskey, Levak, &
Nichols, 2015). Development of the MMPI began in the late 1930s in response to
limitations of existing personality tests, particularly a lack of external validity. Hathaway
and McKinley initially aspired to create a test that could aid in “diagnosing persons
classified as constitutional psychopathic inferiors” (Hathaway, 1939, p. 117) and
“assessing the psychological factors associated with physical problems or disease seen in
a medical practice” (McKinley & Hathaway, 1943, p. 161). Subsequently, they also
hoped their test would “measure the effectiveness of insulin therapy” (Hathaway, 1964,
p. 204) in schizophrenia, which was a popular treatment modality in the late 1930s. The
test also came to be viewed as an aid in defining levels of psychological impairment and
changes in patients’ conditions over time, as well as in observing therapeutic effects
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(Dahlstrom, Welsh, & Dahlstrom, 1972). The MMPI was first published in 1942; by late
April of 1943, the test was generating sufficient revenue that the Psychological
Corporation became its licensed distributor. The final form of the MMPI was released in
1951, with the addition of the Social Introversion scale (Si), published by Drake in 1946.
Further revisions of the MMPI Manual were published through 1983 (Friedman et al.,
2015).
In creating the MMPI, Hathaway and McKinley were motivated to correct many
of the problems hindering the effectiveness of most personality tests at the time. These
personality inventories were generally constructed on a rational basis with a focus on
content validity, but lacked scales focusing on assessment of test takers’ attitudes (e.g.,
defensiveness, over- or under-reporting of symptoms). Hathaway and McKinley utilized
the criterion keying method, an empirical method, in constructing the MMPI. In this
method test items were administered to two or more groups of participants: a criterion
group chosen for homogeneity in regard to a given diagnosis, selection of features, traits,
or other characteristics (e.g., depression), and a comparison group that did not share these
features, or shared them only at base-rate levels. Items to which the criterion and
comparison groups’ responses were statistically different were included in the scale
related to the criterion group’s characteristics, and items that received similar responses
from both groups were excluded. Scoring such scales was done by allotting one point to
each item answered in the direction of occurring significantly more frequently in the
criterion group. For instance, if a greater proportion of individuals with paranoia than
individuals in the control group responded True to an item, a True response to that item
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received one point on the Paranoia scale, while a False response did not receive a score.
Thus, the higher one’s raw score is for any given scale, the more items he or she has
responded to in the direction of the criterion group (Friedman et al., 2015).
Using this criterion keying/contrasted group method, Hathaway and McKinley
began constructing the MMPI by amassing over 1,000 self-reference statements from
various sources, including psychiatric examination forms, psychiatric textbooks, existing
attitude and personality scales, clinical reports, and their own clinical experiences. Five
hundred four separate statements that could be answered True or False made up the initial
item pool; 55 additional items related to masculinity-femininity were later included, nine
of which were eventually removed, resulting in the final pool of 550 items (Friedman et
al., 2015). These items were placed into 26 content areas, including phobias, religious
attitudes, overall health (including medical and neurological symptoms), political and
social attitudes, familial, educational, and occupational experiences, and selfpresentation, particularly in an overly virtuous manner (Dahlstrom et al., 1972). The
items were deemed easily readable, written in the first-person declarative form with
simplified writing based on commonly used vocabulary. Using these 550 items, scales
were developed by contrasting the responses of the comparison and clinical criterion
groups (Friedman et al., 2015).
The comparison group consisted of 724 friends and relatives of patients receiving
treatment at the University of Minnesota Hospital outpatient department who agreed to
complete the MMPI. This group was entirely Caucasian as few ethnic minority groups
resided in Minnesota at the time, belonged to social classes deemed “underprivileged,”
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and came from all areas of the state (Dahlstrom et al., 1972; McKinley & Hathaway,
1940). Further control and patient groups were composed of high school graduates
attending pre-college conferences at the University of Minnesota (n = 265), medical
patients at the University of Minnesota Hospital (n = 254), Work Project Administration
(WPA) personnel (n = 265), and inpatients with various diagnoses in the then-called
University of Minnesota Hospital Psychopathic Unit (i.e., psychiatric unit) (n = 221).
Control participants (other than the medical patients) who were under the care of a
physician at the time were excluded from the normative samples; all other participants
were included (Friedman et al., 2015). Hathaway and McKinley found their original
control sample to be well-matched in age, gender, and marital status to the Minnesota
population according to the 1930s census (Dahlstrom et al., 1972). However, it was later
determined and now generally accepted that the original MMPI norm group was overrepresentative of lower educational and occupational groups (Dahlstrom, 1993).
The clinical criterion groups were made up of carefully chosen psychiatric
patients representing the following major diagnostic categories: hypochondriasis,
depression, conversion hysteria, psychopathy, paranoia, psychasthenia, schizophrenia,
and hypomania. Two extra groups were later included to aid in the development of
additional MMPI scales. One group was comprised of college women used to develop a
Si scale, and the other group, used to develop the Masculinity-Femininity (Mf ) scale
consisted of “homosexual invert males” (Drake, 1946; Hathaway, 1980, p. 10).
The MMPI contained 13 standard scales at its core: three validity scales (Lie [L],
Infrequency [F], and Correction [K]) and ten standard clinical scales (scale 1
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Hypochondriasis [Hs], scale 2 Depression [D], scale 3 Hysteria [Hy], scale 4
Psychopathic Deviate [Pd], scale 5 Masculinity-Femininity [Mf], scale 6 Paranoia [Pa],
scale 7 Psychasthenia [Pt], scale 8 Schizophrenia [Sc], scale 9 Hypomania [Ma], and
scale 0 Social Introversion [Si]). The validity scales were developed in order to aid in
recognizing test records produced by uncooperative or deceptive test-taking strategies
(e.g., faking good or faking bad) or participants who had difficulty in comprehending or
reading the test items (Friedman et al., 2015). The clinical scales were predominantly
developed to contribute to identifying the type and severity of psychiatric conditions,
with a secondary objective being to provide an objective means of estimating effects of
therapy and other changes in patients’ conditions over time (Dahlstrom et al., 1972).
The traditional validity scales of the MMPI were Cannot Say (?), L, F, and K. The
Cannot Say score is the number of items left unmarked or marked both True and False by
the test taker. In either instance, the response is rendered unscorable. The Infrequency
scale (F) was developed to measure the tendency of the test taker to respond to items in
an unusual fashion. Items included in the F scale represent a varied array of content that
obviously suggest deviant behavior, thus making it relatively easy for test takers to either
deny or over-report problems (Friedman et al., 2015). Fortunately, a meta-analytic review
conducted by Berry, Baer, and Harris (1991) found that F scores (particularly raw-score
F values) are one of the most powerful measures on the MMPI in detecting faking. The
Lie scale (L) was designed as a validity indicator to detect intentional under-reporting of
problems, or “faking good.” All 15 items on the scale are keyed False and were derived
rationally from previous research on honesty and conceit by Hartshorne and May (1928).
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A high L score reflects feelings of virtue and denial of minor character faults. Lastly, the
Correction scale (K) was originally developed in order to improve the sensitivity of the
clinical scales to detect psychopathology by adding a correction or suppression factor to
their scaled scores. Without this correction, excessive false negative or low-ranging
MMPI scores were found among psychiatric patients who should have demonstrated
elevations on certain clinical scales due to their psychopathology. The goals of designing
the K scale were aimed primarily at reducing these false negatives without significantly
affecting the number of accurate test hits (true positives or true negatives). Additionally,
correct interpretation of the K scale can aid in assessing fake-bad and fake-good test
attitudes (Friedman et al., 2015).
Scale 1 (Hs) was the first to be included in the MMPI, largely due to the great
numbers of patients with this disorder that were available, and because this diagnosis was
rather easy to determine (McKinley & Hathaway, 1940). This scale measures bodily
complaints or somatic ailments reported by an individual, that is, the degree to which an
individual is denying good physical health. Hypochondriasis involves unrealistic
interpretation of physical symptoms or sensations as abnormal, which leads the afflicted
individual to fear that he or she has a serious disease (American Psychiatric Association,
2013). The MMPI Hs criterion group was made up of 50 inpatients with only pure,
uncomplicated hypochondriasis. Patients with coexisting disorders, such as psychosis or a
physical condition, were excluded from the criterion group (Friedman et al., 2015).
Scale 2 (D) was designed to gauge the presence and magnitude of symptoms of
depression, a mood state characterized by decreased morale, feelings of hopelessness
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and/or worthlessness, slowing of thought and/or action, and possible preoccupations with
death and/or suicide (Dahlstrom et al., 1972). D is thought of as a mood scale (state vs.
trait), and as such, is sensitive to transient and brief emotional states, such as declines in
morale and efficiency (Friedman et al., 2015). Thus, D is useful in measuring response to
treatment, and is even generally more sensitive to genuine health/illness states than scores
on scale 1 (Nichols, 2011). Five participant groups were used to construct scale 2, but
most of its 60 items were derived by comparing participants without observable
depression with a group of 50 patients who had been diagnosed as being in the depressed
phase of a manic-depressive psychosis (Hathaway & McKinley, 1942). A group of
depressed “normal” individuals was also included in the creation of the scale in order to
help establish more intermediate scale values between the comparison and criterion
groups (Friedman et al., 2015).
The diagnosis of hysteria was quite common in the 1930s; however, it was
difficult to determine as definite diagnostic criteria were lacking, hysterical phenomena
commonly co-occurred with other neurotic symptoms in the same individual, and there
was diagnostic uncertainty of hysterical reactions in individuals suspected of having
organic disease (McKinley & Hathaway, 1944). Thus, Scale 3 (Hy) was originally
created to assist in the diagnosis of hysteria, as well as to measure the degree to which
patients were likely to develop symptoms of conversion. Conversion symptoms included
“fits” such as blackouts, fainting, and pseudoseizures, abdominal pain, vomiting,
amnesia, paralysis, contractures, tremors, speech irregularities (e.g., mutism, stammer,
stutter, lisp, whispering), spasmodic movements, awkward or impaired gait, episodic
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weakness and/or fatigue, anesthesia, deafness, blindness, blurred or tunnel vision, and
cardiac crises, such as palpitations. The 50 participants in the Hy criterion group were
primarily inpatients in the University of Minnesota Hospital psychiatric unit. Each had
received a diagnosis of psychoneurosis or hysteria, or had been noted as having
particularly hysterical components in a personality disturbance (Friedman et al., 2015).
The patients of the criterion group manifested “neurotic defense of the conversion form
of hysteria” (Dahlstrom et al., 1972, p. 191).
Scale 4 (Pd) was designed to measure the “personality characteristics of the
amoral and asocial subgroup of persons with psychopathic personality disorders”
(Dahlstrom et al., 1972, p. 195). The name of this scale, Psychopathic Deviate, implies “a
variation in the direction of psychopathy,” in accordance with the American Psychiatric
Association’s definition of psychopathic personality at the time, which included
pathological emotionality and sexuality, along with asocial or amoral attitudes (McKinley
& Hathaway, 1944, p. 172). McKinley and Hathaway (1944) found the scale was
successful in identifying approximately half of the cases repeatedly classified as clinical
psychopathic personalities. The criterion group was comprised of an undisclosed number
of men and women ages 17 to 22. Symptomatically, the criterion cases varied greatly, but
were characterized by complaints of stealing, lying, truancy, sexual promiscuity, overindulgence in alcohol, forgery, and like behaviors. A common factor among the criterion
group appeared to be low anticipation of their behavior’s consequences, as well as an
inability to learn to anticipate such consequences and cease engaging in antisocial
behavior. The general construct of Pd appears to be one of an ingrained and mostly
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maladaptive pattern of personality and behavior that generally involves some degree of
externalization, such that problems and conflicts are perceived as originating outside of
the self, dishonesty, selfishness, disloyalty, and/or malice (Greene, 2011).
Scale 5 (Mf) was originally intended to distinguish between homosexual and
heterosexual men (Graham, 2011). Three subgroups of homosexual men were used for
scale development based on the etiology of their gender preference. The first group
consisted of “pseudo-homosexuals” with neurotic features related to inferiority. The
second subgroup was a psychopathic type who tended to elevate scale 4, and the third
subgroup became the final criterion group. This group was made up of 13 homosexual
men screened for psychological abnormalities, such as psychosis, evident neurotic
tendencies, and psychopathy. Hence, their homosexuality was not deemed to be caused
by or related to any psychological condition. These men were seen as having feminine
dispositions evident in their expressive styles, interests, and attitudes (Dahlstrom et al.,
1972). Subsequent comparison groups consisted of 67 female airline employees and 54
male soldiers whose scores were compared to ascertain their response frequencies by
gender (Hathaway & McKinley, 1943). A second comparison step involved identifying
men who scored in the “feminine” direction on an “Invert” scale derived from Terman
and Miles (1936). The responses of these men were then compared to those of a group of
“normals.” Contrary to the scale’s original intent, scale 5 does not adequately
differentiate homosexual men from their heterosexual counterparts (Wong, 1984).
Instead, it came to be used to assess gender-role conformity and gender-related interests
(Friedman et al., 2015).
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According to Hathaway (1980), scale 6 (Pa) was designed to assess paranoid
symptoms and features. The paranoid criterion group patients had diagnoses of paranoid
state, paranoid condition, or paranoid schizophrenia. These patients displayed several
symptoms of paranoia including ideas of reference, feelings of persecution, grandiose
self-thoughts, hypersensitivity, rigid thinking, and suspiciousness. Accordingly, the scale
measures a range of chronic and acute paranoid ideations and attitudes including
delusions of control, persecutory ideation/delusions, hypersensitivity, and denial of
cynicism. Externalizing processes including projection, hypervigilance, and scanning for
“evidence” of hostile intentions or actions were also assessed (Friedman et al., 2015).
Scale 7 (Pt) was developed to measure a neurotic pattern labeled psychasthenia, a
now obsolete term used to denote neuroses dominated by “doubting, agitation, and
anxiety and by obsessional ideas” (Berrios, 1985, p. 174). Psychasthenia involves an
inability to disengage in undesired, maladaptive behaviors, which stems from the concept
of a “weakened will” according to McKinley and Hathaway (1942, p. 616).
Psychasthenic tendencies as defined by the original MMPI included excessive self-doubts
and worries that lead to tension, difficulty in making decisions, various fears, obsessive
preoccupations, compulsive urges and behaviors, ambiguous anxieties, and feelings of
low self-confidence and insecurity. In the past, psychasthenic conditions were often
referred to as compulsion neuroses, obsessive-compulsive states, or obsessive-ruminative
tension states (McKinley, 1944). Today, the appropriate diagnostic category for
psychasthenia would be obsessive-compulsive disorder (DSM-5; American Psychiatric
Association, 2013). Scale 7 does not contain items reflecting specific phobias or
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compulsions. Instead, the underlying personality structure of psychasthenia, rather than
specific symptomatology, is presented in the items of Scale 7 (Friedman et al., 2015).
Dementia Praecox was recognized as a syndrome by Kraepelin (1893), and was
later renamed Schizophrenia by Bleuler in 1911 (e.g., Bleuler, 1950). Schizophrenia is
currently recognized as a group of disorders with a biogenetic etiological basis (Eysenck,
Wakefield, & Friedman, 1983; Gallagher, Jones, & Baraket, 1987), and its diagnostic
criteria, according to DSM-5, include impairment of psychological processes involving
thinking, perceiving, feelings, speaking, and behaving, with no one symptom considered
characteristic of the disorder (American Psychiatric Association, 2013). Deterioration
from a prior level of functioning is frequently observed with constant symptoms of the
disorder present for at least six months before diagnosis. Symptoms include social
withdrawal, inappropriate affect, delusion, odd behavior, hallucinations, and digressive,
vague, circumstantial, or disorganized speech. Scale 8 (Sc) measures these characteristics
of schizophrenia. Individuals in the Sc criterion group were diagnosed with various
subtypes of schizophrenia that are not recognized in the DSM-5 (e.g., catatonic, paranoid,
simple, and hebephrenic). Thus, the wide range of symptoms that can be present in
schizophrenia were represented (Friedman et al., 2015).
Scale 9 (Ma) was the last of the basic Clinical scales to be developed and
measures aspects of a mildly elevated mood, including flight of ideas, labile affect, and
psychomotor excitement (Friedman et al., 2015). Ma reflects the personality pattern
hypomania, an affective disorder involving heightened activity levels along with easy
distractibility, insomnia, excessive optimism, grandiosity, suspiciousness, and irascibility
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(Dahlstrom et al., 1972). Twenty-four inpatients at the University of Minnesota Hospital
were selected as the Ma criterion group. Only patients with less than full-blown mania
were considered for inclusion, as more severe cases were unable to fully engage in
sorting items into the True, False, and Cannot Say categories. Thus, the scale name
Hypomania denotes measurement of a less than full-blown manic condition. It was
important to develop a measure of more moderate or subtle cases of mania in order to
identify the condition early on and improve prognosis and treatment options for the test
taker (Friedman et al., 2015).
Scale 0 (Si) was originally developed to assess an individual’s degree of
introversion- extraversion (Drake, 1946). Si is the only MMPI scale to have a criterion
group comprised of a non-psychiatric (“normal”) sample. Development of the Si scale
was inspired by the Minnesota T-S-E (Thinking-Social-Emotional) Inventory, which was
then often administered at the University of Wisconsin guidance program. The T-S-E
Inventory was developed by Evans and McConnell (1941) and separated the character
traits of introversion-extraversion into categories of thinking, social activity, and
emotional expression. Drake developed a similar scale measuring social introversion
from the MMPI using two female criterion groups: 50 college students who scored at the
65th percentile or higher on the social introversion-extraversion component of the T-S-E
Inventory, and 50 college students who scored below the 35th percentile. While the scale
was initially scored using only women, it was later validated with men, and male and
female groups were combined into one group in order to establish Si norms. (Friedman et
al., 2015).
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The raw scores of each MMPI Validity and Clinical scale are converted into
standard T-scores by plotting them onto a profile. The pattern of high scores is what is
typically interpreted; these scores provide the interpreter the ability to compare the test
taker’s scores to the test norms. Individual scales were initially interpreted to aid in
diagnosis. However, combinations of scales were later determined to be better descriptors
of personality characteristics, such that patterns of scale scores rather than single scale
elevations became the primary focus of interpretation rather than single scale elevations.
“Codetype” or “Code Pattern” became the terms used to describe configural
interpretation of the MMPI profile (Friedman et al., 2015).
Additional research-based scales came to be incorporated into the MMPI beyond
its original 13 scales. As high scores on certain clinical scales can be better understood by
examining components that make up the broader constructs they measure, Harris and
Lingoes (1955, 1968) developed a set of rational, content-based subscales (named HarrisLingoes Subscales) for Clinical scales 2, 3, 4, 6, 8, and 9. Wiggins (1966) developed a
series of 13 content scales containing items with straightforward descriptions of
symptoms and problems. The Content scales were designed to allow patients to express
their symptoms and concerns in a more direct manner than on the Clinical scales.
Furthermore, hundreds of research-based supplementary scales were developed for the
MMPI, some of which came to be included into the standard test profile. These included
factor scales Anxiety (A) and Repression (R) (Welsh, 1956); an Ego Strength scale (Es;
Barron, 1953); a Low Back Pain scale (Lb; Hanvik, 1949); a Caudality scale (Ca;
Williams, 1952); a Dependency scale (Dy; Navran, 1954); a Social Responsibility scale
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(Re; Gough, McClosky, & Meehl, 1952); Prejudice (Pr; Gough, 1951) and Social Status
(St; Gough, 1948a, 1948b) scales; a Control scale (Cn; Cuadra, 1956); a Manifest
Anxiety scale (At or MAS; Taylor, 1953); a College Maladjustment scale (Mt;
Kleinmuntz, 1961); an Alcoholism scale (Alc or MAC; MacAndrew, 1965); and an
Overcontrolled-Hostility scale (O-H; Megargee, Cook, & Mendelsohn, 1967) (as cited in
Friedman et al., 2015). Thus, the MMPI instrument evolved and became more
comprehensive than its original version.
MMPI-2.
The development of the MMPI-2 (Butcher et al., 1989) began in 1982 based on
two identified needs. First, the most apparent need was the collection of new norms. The
original MMPI normative sample had been collected in the 1930s and was composed
almost entirely of Caucasian, working-class, rural-dwelling individuals from Minnesota
who had obtained eight years of education, on average. While this sample was
appropriate when the MMPI was published, it became inadequate as the MMPI became
more widely used in the United States and around the world. Secondly, the revision of the
MMPI aimed to update its test items. Items that were not scored on any of the more
widely used scales and those deemed offensive on the bases of religious beliefs, sexist
wording, or mention of bowel and bladder functioning, were removed from the item pool.
Additionally, items containing outdated language or cultural references were revised. The
original validity scales were carried over from the MMPI to the MMPI-2. Similarly, the
Clinical scales were essentially left unchanged, although some items were revised or
eliminated from the scales (Ben-Porath & Tellegen, 2008). The original Wiggins content
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scales were replaced with a set of 15 new MMPI-2 Content scales to address areas such
as fears, anger, and family problems not assessed by the Clinical scales. These scales
include: Anxiety (ANX), Fears (FRS), Obsessiveness (OBS), Depression (DEP), Health
Concerns (HEA), Bizarre Mentation (BIZ), Anger (ANG), Cynicism (CYN), Antisocial
Practices (ASP), Type A Behavior (TPA), Low Self-Esteem (LSE), Social Discomfort
(SOD), Family Problems (FAM), Work Interference (WRK), and Negative Treatment
Indicators (TRT) (Friedman et al., 2015). Additionally, a standard set of supplementary
scales was selected for the MMPI-2 Supplementary scales profile, which includes the
following: A and R (Welsh, 1956); Es (Barron, 1953); Dominance (Do; Gough,
McClosky, & Meehl, 1951); Re (Gough et al., 1952); Mt (Kleinmuntz, 1961); PostTraumatic Stress Disorder scales PK (Keane, Malloy, & Fairbank, 1984) and PS
(Schlenger & Kulka, 1987); the Marital Distress Scale (MDS; Hjemboe, Almagor, &
Butcher, 1992); Hostility (Ho; Cook & Medley, 1954); O-H (Megargee et al., 1967);
Alcoholism scale- Revised (MAC-R; MacAndrew, 1965); Addiction Admission (AAS)
and Addiction Potential (APS) (Hathaway & McKinley, 1989); and Gender RoleMasculine (GM) and Gender-Role- Feminine (GF) (Hathaway & McKinley, 1989). BenPorath and Sherwood (1993) later developed subscales for content scales with
heterogeneous content, which they titled components. Another important addition
consisted of the Personality Psychopathology-Five (PSY-5) scales intended to measure
major domains of disordered personality (Harkness, McNulty, & Ben-Porath, 1995).
These include Aggressiveness (AGGR), Psychoticism (PSYC), Disconstraint (DISC),
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Negative Emotionality/Neuroticism (NEGE), and Introversion/Low Positive Emotionality
(INTR).
An experimental form (Form AX) was created in order to test a new group of
“normal” participants, as well as to provide a basis for developing the new MMPI-2.
Form AX contained all 550 items from the MMPI, as well as 154 new experimental
items, for a total of 704 items. Some item order change occurred, although this was likely
inconsequential. Eight-two original MMPI items were rewritten for Form AX to improve
the clarity or modernity of their language. Ultimately, 14 of these items were eliminated,
resulting in 68 original items left in the MMPI-2 (Friedman et al., 2015). Additionally, 47
of the 154 experimental items were also eliminated from the MMPI-2 (Nichols, 1992, as
cited in Friedman et al., 2015). The original MMPI-2 was published in 1989; it consists
of 567 items and introduced several improvements to the original MMPI, which was
discontinued by its publisher in 1999. First, new norms, which were more representative
of the United States’ population, were provided. Two thousand six hundred adult paid
volunteers (1,462 women and 1,138 men, all ages 18 to 85) were selected from
California, Minnesota, North Carolina, Ohio, Pennsylvania, Virginia, and Washington to
participate as the MMPI-2 normative sample. This new sample was more ethnically
diverse than the original sample as it included African-Americans, Hispanics, and Native
Americans; however, in comparison with 1990 census data, Asian-Americans and
Hispanics were still underrepresented in the MMPI-2 normative sample. Furthermore,
young adults in the age range of 18 to 19, as well as older adults ages 70 to 84 were also
underrepresented (Friedman et al., 2015).
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A new method of deriving MMPI-2 standard scores was introduced, as were
several new scales. Two new response inconsistency scales, VRIN and TRIN, were
developed to assist in identifying protocols demonstrating random or biased responding.
A new scale, F-back (Fb), was designed to identify infrequent responding to items in the
second half of the MMPI-2. Further research and development of the MMPI-2 following
its initial release resulted in additional MMPI-2 scales. Two Validity scales, InfrequencyPsychopathology (Fp; Arbisi & Ben-Porath, 1995a; 1995b) and the Superlative SelfPresentation scale (S; Butcher & Han, 1995) were introduced, with Fp assessing the
likelihood that a high F scale reflects exaggeration rather than genuine psychopathology,
and S detecting an unrealistically virtuous self-presentation. Subsequent developments
also introduced non-gendered MMPI-2 norms and the addition of the Symptom Validity
Scale (FBS) to the Validity scales (Ben-Porath & Tellegen, 2008).
The Variable Response Inconsistency scale (VRIN) consists of 67 pairs of items
intended to detect inconsistent, contradictory responding (Friedman et al., 2015). Each
item pair has similar or opposite meaning (Butcher et al., 2001). Some items are scored as
inconsistent if one item receives an opposite response from the other item in the pair,
while others are scored as inconsistent if both items are scored alike. Very high VRIN
scores suggest the test taker may not have responded carefully to the test items, thus
causing the profile to be uninterpretable. The True Response Inconsistency scale (TRIN)
is comprised of 23 item pairs that are opposite in content (Friedman et al., 2015). A high
TRIN score reflects biased responding in either an acquiescent (True) or nay-saying
(False) direction (Butcher et al., 2001, as cited in Friedman et al., 2015). The Fb scale
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was designed for the MMPI-2 to function similarly to the F scale, but for items appearing
later in the test. The F scale is scored within the first 361 items of the MMPI-2; when the
test was re-standardized from the MMPI, the Fb scale was developed to pick up where
the F scale left off. The Fb scale begins at Item 281 (Friedman et al., 2015). The Fp scale
was designed by Arbisi and Ben-Porath (1995a; 1995b) to provide further measurement
of self-unfavorable or over-reporting, especially in patient populations in which higher
rates of endorsement of psychological disturbance are anticipated. As there are several
reasons as to why an elevation on F might occur, such as random responding, poor
reading comprehension, genuine psychopathology, or attempting to “fake bad,” Fp was
designed to better understand F elevations. The Fp scale was constructed with items
rarely endorsed by two groups of patients with known psychiatric disturbance, and by
individuals from the MMPI-2 re-standardization sample. Therefore, an elevation on Fp
indicates the test taker endorsed items rarely endorsed by psychiatric patients and
individuals from the general population, and suggests the score was the result of a
“faking bad” response style (Friedman et al., 2015). The final Validity scale addition to
the first publication of the MMPI-2 was the S scale. This scale was developed by Butcher
and Han (1995) by comparing item responses of 274 male airline pilot applicants with the
1,138 men from the MMPI-2 re-standardization sample. The scale contains fifty items
that differed significantly in endorsement frequency between the two groups and added to
its internal consistency based on item and content analyses. S is similar to K in that both
scales may be considered measures of defensiveness. Unlike K, however, S extends
throughout the MMPI-2 until Item 560, while K items are found prior to Item 366
53

(Friedman et al., 2015). Additionally, the content of S is less subtle than that of K and is
more socially desirable, accentuating characteristics such as denial of cynicism, mistrust,
irritability, anxiety, and internal conflict, and assertion of benevolent views toward
others, contentment with one’s life, an even temper, and conventionality (Nichols, 2011).
The newest among the MMPI-2 Validity scales is the Symptom Validity Scale (FBS,
formerly Fake Bad Scale). The FBS was developed by Lees-Haley, English, and Glenn in
1991, but it was not added to the official MMPI-2 scoring program until January, 2007.
This scale is a supplemental measure of validity intended to detect malingering in
plaintiffs involved in personal injury litigation (Friedman et al., 2015).
The aspect of the MMPI-2 which most directly relates to the later development of
the MMPI-2-RF is the introduction of the Restructured Clinical (RC) scales to the
MMPI-2. While the MMPI-2 Clinical scales have been recognized as demonstrating
strength due to containing items that reflect clinically significant dimensions, one
downfall is that these scales are not psychometrically optimal. For instance, the MMPI-2
Clinical scales each contain heterogeneous item content, item overlap across them, and
consequent high inter-correlations across Clinical scale scores. The RC scales were
designed to address these problems. Each RC scale measures a homogenous dimension
identified as a major component of one or more Clinical scale(s), and are as follows:
Somatic Complaints (RC1), Low Positive Emotions (RC2), Cynicism (RC3), Antisocial
Behavior (RC4), Ideas of Persecution (RC6), Dysfunctional Negative Emotions (RC7),
Aberrant Experiences (RC8), and Hypomanic Activation (RC9). The shared variance
across Clinical scales related to distress was placed into a single Demoralization (RCd)
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scale. The RC scales offer considerable value as measures of several distinct core
components of the Clinical scales, but were not considered sufficient for a comprehensive
MMPI-2 based assessment of clinically relevant features. Scales measuring aspects of the
original Clinical scales (e.g., shyness, anxiety, aggression, substance abuse) and other
facets not assessed, or not directly assessed, by the RC scales (e.g., interests, suicidal
ideation, fears) were also needed. Furthermore, the RC scales did not include measures of
the core components of Clinical scales 5 and 0. While these scales are not measures of
psychopathology, both assess attributes relevant to comprehensive psychological
assessment. Lastly, a set of higher-order dimensions remained unidentified by the RC
scales (Ben-Porath & Tellegen, 2008).
MMPI-2-RF.
The MMPI-2-RF (Ben-Porath & Tellegen, 2008) is a 338-item restructured
version of the 567-item MMPI-2 that includes the previously discussed MMPI-2 RC
scales along with newly developed scales. The MMPI-2-RF was designed to provide
comprehensive and efficient assessment of clinically relevant variables measurable by its
item pool, and is intended for use in a variety of settings. Each item included in the
MMPI-2-RF comes from the MMPI-2. Additionally, the MMPI-2-RF shares the same
normative sample as the MMPI-2. New norms were deemed unnecessary based on the
test developers’ examination of data from recent cohorts whose mean scores were found
to be similar to those of the MMPI-2 normative sample. One major distinction between
the norms of these two instruments is that the norms for the MMPI-2 are provided
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separately for each gender, while the MMPI-2-RF uses non-gendered norms (Ben-Porath
& Tellegen, 2008).
One goal of developing the MMPI-2-RF was to assess the entire pool of MMPI-2
items and select potential areas for further scale construction (Ben-Porath & Tellegen,
2008). The MMPI-2-RF was intended to be a useful alternative to, rather than
replacement for, the MMPI-2 (Graham, 2011). This restructured version now contains 51
scales with several of the MMPI-2-RF scales being constructed using like procedures or
containing many of the same items as those on the MMPI-2. The nine RC scales of the
MMPI-2 make up the core of the MMPI-2-RF and are joined by seven revised Validity
scales (VRIN-r, TRIN-r, F-r, Fp-r, FBS-r, L-r, and K-r) and one new Validity scale
(Infrequent Somatic Responses [Fs]). Each of the seven revised MMPI-2-RF Validity
scales are quite similar to their MMPI-2 counterparts and are used to assess deviant
response patterns in the same way as their antecedent versions (Tellegen & Ben-Porath,
2008). The new Fs scale was created by Wygant, Ben-Porath, and Arbisi (2004) to
highlight overreporting of uncommon somatic symptoms.
Three new Higher-Order (H-O) scales (Internalizing Dysfunction [EID], Thought
Dysfunction [THD], and Behavioral/Externalizing Dysfunction [BXD]) are introduced in
this test version. Tellegen and Ben-Porath (2008) devised the Higher-Order scales to
identify the major dimensions of the MMPI-2-RF scales and provide an organized
structure for interpretation of the substantive scales. Three consistent factors, EID, THD,
and BXD, were the result of factor analyses of the RC scales in three clinical samples.
Other scales were then developed to measure these dimensions by correlating the three
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factor scores with the 567-item MMPI-2- item pool. The majority of the EID scale items
come from the RCd, RC2, and RC7 scales; most of the THD scale items come from scales
RC6 and RC8; and most of the scale items for the BXD scale come from the RC4 and
RC9 scales. Therefore, the Higher-Order scales represent the core constructs of three
frequently occurring MMPI-2 code types (27/72, 68/86, and 49/94, respectively)
(Graham, 2011).
As the RC scales do not assess every important clinical construct included in the
MMPI-2 item pool, Ben-Porath and Tellegen (2008) designed 23 Specific Problems
scales for the MMPI-2-RF. These scales were developed to measure distinctive Clinical
scale components not assessed by the RC scales, facets of the RC scales that warranted
separate assessment, and clinically significant attributes not represented by the RC scales.
The SP scales are divided into four groups based on content which are: Somatic scales,
Internalizing scales, Externalizing scales, and Interpersonal scales. The Somatic scales
cluster contains Malaise (MLS), Gastrointestinal Complaints (GIC), Head Pain
Complaints (HPC), Neurological Complaints (NUC), and Cognitive Complaints (COG).
The scales of the Internalizing scales group are Suicidal/Death Ideation (SUI),
Helplessness/Hopelessness (HLP), Self-Doubt (SFD), Inefficacy (NFC), Stress/Worry
(STW), Anxiety (AXY), Anger Proneness (ANP), Behavior-Restricting Fears (BRF), and
Multiple Specific Fears (MSF). The Externalizing scales consist of Juvenile Conduct
Problems (JCP), Substance Abuse (SUB), Aggression (AGG), Activation (ACT), and the
Interpersonal scales contain Family Problems (FML), Interpersonal Passivity (IPP),
Social Avoidance (SAV), Shyness (SHY), and Disaffiliativeness (DSF) (Graham, 2011).
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The MMPI-2-RF also presents two new Interest Scales (Aesthetic-Literary Interests
[AES] and Mechanical-Physical Interests [MEC]). These Interest scales were created
based on factor analyses of MMPI-2 Masculinity-Femininity scale items, from which two
independent dimensions were identified. The first scale, AES, consists of seven items
related to interest in writing, music, and theater, while the second scale, MEC, contains
nine items having to do with interest in fixing or building things, outdoor activities, and
sports. Lastly, the MMPI-2-RF also contains revised versions of the MMPI-2 PSY-5
scales (AGGR-r, PSYC-r, DISC-r, NEGE-r, and INTR-r) (Graham, 2011). These scales
conceptually link the MMPI instruments with contemporary models of personality and
psychopathology (Graham, 2011). Table 1 presents the MMPI-2-RF scales and their
measured characteristics.
Table 1
MMPI-2-RF scales and measured characteristics
Scale Name
Validity Scales

Characteristic

Cannot Say (?)

Unanswered items

Variable Response Inconsistency (VRIN-r)

Random response pattern

True Response Inconsistency (TRIN-r)

Inconsistent response pattern related to
acquiescent or nay-saying response bias

Infrequent Responses (F-r)

Responses suggesting high disturbance
that is rare in the general population

Infrequent Psychopathology Responses
(Fp-r)

Responses suggesting high disturbance
that is rare in psychiatric populations
(table continues)
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Table 1 (cont.)
MMPI-2-RF scales and measured characteristics
Scale Name

Characteristic

Infrequent Somatic Responses (Fs)

Somatic symptoms infrequently endorsed
in medical patient populations

Symptom Validity (FBS-r)

Somatic and cognitive complaints
associated with over-reporting of
symptoms

Uncommon Virtues (L-r)

Unrealistic moral attributes, values, or
actions

Adjustment Validity (K-r)

Avowals of good psychological
adjustment; associated with defensiveness
(indicated by under-reported
maladjustment) at high levels

Higher-Order (H-O) Scales
Emotional/Internalizing Dysfunction (EID)

Disturbance in mood and affect

Thought Dysfunction (THD)

Disturbance associated with disordered
thinking

Behavioral/Externalizing Dysfunction
(BXD)

Disturbance associated with undercontrolled behavior

Restructured Clinical (RC) Scales
Demoralization (RCd)

General unhappiness and dissatisfaction

Somatic Complaints (RC1)

Varied physical health complaints

Low Positive Emotions (RC2)

Deficiency of positive emotionality

Cynicism (RC3)

Non-self-referential beliefs expressing
mistrust and generally low opinions of
others

Antisocial Behavior (RC4)

Rule-breaking and irresponsible behavior
(table continues)
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Table 1 (cont.)
MMPI-2-RF scales and measured characteristics
Scale Name

Characteristic

Ideas of Persecution (RC6)

Self-referential beliefs that others are
threatening

Dysfunctional Negative Emotions (RC7)

Maladaptive anxiety, anger, frustration

Aberrant Experiences (RC8)

Unusual perceptions or cognitions

Hypomanic Activation (RC9)

Over-activation, aggression, impulsivity,
and grandiosity

Specific Problems (SP) Scales
Somatic/Cognitive Scales
Malaise (MLS)

General sense of physical debilitation,
poor health

Gastrointestinal Complaints (GIC)

Nausea, recurring upset stomach, and
poor appetite

Head Pain Complaints (HPC)

Head and neck pain

Neurological Complaints (NUC)

Dizziness, weakness, paralysis, loss of
balance, etc.

Cognitive Complaints (COG)

Difficulties with memory, concentration

Suicidal/Death Ideation (SUI)

Direct reports of suicidal ideation and
recent suicide attempts

Helplessness/Hopelessness (HLP)

Belief that goals cannot be reached or
problems solved

Self-Doubt (SFD)

Lack of confidence, feelings of
inferiority
(table continues)
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Table 1 (cont.)
MMPI-2-RF scales and measured characteristics
Scale Name

Characteristic

Inefficiency (INF)

Belief that one is indecisive and
ineffectual

Stress/Worry (STW)

Preoccupation with disappointments,
difficulty managing under pressure

Anxiety (ANX)

Pervasive anxiety, fears, frequent
nightmares

Anger Proneness (ANP)

Becoming easily angered, impatient

Behavior-Restricting Fears (BRF)

Fears that significantly inhibit daily
functioning

Multiple Specific Fears (MSF)

Fears of blood, water, thunderstorms, etc.

Externalizing Scales
Juvenile Conduct Problems (JCP)

Problematic behaviors at home and
school

Substance Abuse (SUB)

Current and past misuse of alcohol
and/or drugs

Aggression (AGG)

Physically aggressive, violent behavior

Activation (ACT)

Heightened excitement and energy levels

Interpersonal Scales
Family Problems (FML)

Conflict within familial relationships

Interpersonal Passivity (IPP)

Submissiveness, lack of assertion

Shyness (SHY)

Bashful, prone to feel awkward and
anxious around others
(table continues)
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Table 1 (cont.)
MMPI-2-RF scales and measured characteristics
Scale Name

Characteristic

Disaffiliativeness (DSF)

Disliking people and interacting with
them

Interest Scales
Aesthetic-Literary Interests (AES)

Literature, music, the theater

Mechanical-Physical Interests (MEC)

Fixing and building things, the outdoors,
sports

Personality-Psychopathology Five (PSY5) Scales
Aggressiveness-Revised (AGGR-r)

Instrumental, goal-targeted aggression

Psychoticism-Revised (PSYC-r)

Disconnection from reality

Disconstraint- Revised (DISC-r)

Under-controlled behavior

Negative Emotionality/NeuroticismRevised (NEGE-r)

Anxiety, insecurity, worry, fear

Introversion/Low Positive EmotionalitySocial disengagement, lack of pleasure
Revised (INTR-r)
Note. Adapted from Ben-Porath and Tellegen, 2008
MMPI, MMPI-2, and MMPI-2-RF Assessment in Health-Related Contexts
Health psychology assessment has been defined as “assessment of the interactions
of the patient, the disease, and the person’s environment, leading to the formulations of a
diagnostic or treatment strategy based on an understanding of the biopsychosocial
interaction” (Rozensky, Pereira, & Whitehead, 2016, p. 219). The use of assessment
measures in health psychology settings typically serves to provide valid formulation by
integrating components of the biopsychosocial model to assist in integrated treatment
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planning (Rozensky et al., 2016). Additionally, health psychology assessment often
answers questions and, by extension, solves problems related to patient care for other
healthcare professionals (Belar & Deardorff, 1995). Such issues likely to be encountered
in multidisciplinary healthcare settings include psychological presentations and
complications of organic disease, psychological reactions to organic disease, somatic
effects of psychological distress, and somatic presentations of psychiatric disorder
(Lipowski, 1967).
Health psychology assessment involves evaluation of patients presenting with a
wide range of physical illnesses and psychological disorders. With regards to physical
disease alone, psychological assessment has been utilized in patient conceptualization
and treatment planning for metabolic and endocrine disorders, nervous system diseases,
circulatory and respiratory system diseases, diseases of the digestive system and skin, and
many others (Boll, Johnson, Perry, & Rozensky, 2002). Common presenting problems
frequently encountered by psychologists in healthcare settings are management of cancer,
pain, obesity, and need for bariatric surgery (Rozensky, Pereira, & Whitehead, 2016).
Substantial research has been conducted with regards to the MMPI instruments
and physical health conditions in particular (e.g., Mayerink, Reitan, & Selz, 1988;
Strassberg, Reimherr, Ward, Russell, & Cole, 1981; Slesinger, Archer, & Duane, 2002),
as the MMPI measures have long been used in medical settings. Indeed, the original
MMPI was developed for use in medical settings to aid in differentiating patients with
genuine medical complaints from patients whose problems had underlying psychological
symptoms, and was intended for assessment of both psychiatric and general medical
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patients (Arbisi & Seime, 2006; McKinley & Hathaway, 1943). Research concerning the
MMPI in health-related contexts has focused on the previously mentioned most common
presenting problems seen by psychologists in healthcare settings, particularly chronic
pain. Chronic pain has been a serious health and economic concern in the United States
for several decades. During the time of the MMPI’s use, the National Institutes of Health
(1979) estimated that 15 million Americans suffered from low back pain, and the annual
medical care cost for these individuals was $5 billion. Brena, Chapman, and Decker
(1981) estimated these costs to be higher: For one million pain-disabled patients per year,
the cost to society was $20 billion per year. These differences in cost between medical
care for chronic pain patients and costs for society are partly due to the risk for
psychological dysfunction and losses of social, vocational, and financial support
frequently associated with the chronic pain condition. Psychological factors may also
exacerbate the pain experience, may affect response to medical and/or surgical
intervention, and, in some cases, may be the primary factor responsible for the pain
(Prokop, 1988).
Some research has suggested that pain of longer duration has been associated with
more frequent high scores on MMPI profiles (e.g., Cox, Chapman, & Black, 1978;
McGill, Lawlis, Selby, Mooney, & McCoy, 1983), while other studies have not
demonstrated such a relationship (e.g., Armentrout, Moore, Parker, Hewett & Feltz,
1982; McCreary, 1985). However, it is generally agreed upon that pain of greater
intensity is related to more high scores on MMPI profiles. A study conducted by
Strassberg, Reimherr, Ward, Russell, and Cole (1981) illustrates these relationships. This
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study also demonstrated the ability of the MMPI to predict long-term (e.g., approximately
4 years) outcomes of psychiatric and anesthesiologic treatment for chronic pain.
Regardless of whether chronic pain patients received psychiatric or anesthesiologic
treatment, better medical (i.e., number of doctors consulted, hospitalizations, and
surgeries since treatment) and subjective (i.e., current level of pain, current pain in
comparison with pretreatment level of pain, helpfulness of treatment, maximum relief,
length of effectiveness of treatment, and overall success of treatment) outcomes were
associated with less defensiveness (i.e., lower scores on K scale) and fewer psychological
undertones in pain complaints (i.e., lower scores on Hy and Hs scales) on the MMPI.
Mayerink, Reitan, and Selz’s 1988 study investigated MMPI profiles of multiple
sclerosis (MS) patients (n = 83) in comparison to a control group selected from the
MMPI normative group (n = 83, with the same male-to-female ratio as the MS patient
group). MS patients endorsed previously selected “symptom items” on scales 1, 2, 3, 7,
and 8 at a much higher rate than they did non-symptom items; furthermore, the patients
endorsed symptom items at a much higher rate than did the control group.
The focus of the MMPI’s utility in healthcare settings has shifted in recent years.
Since its inception in 1982, the MMPI-2 has remained one of the most widely used
psychological assessment instruments in medical settings, with its most common uses in
these venues being screening for psychopathology, substance abuse problems,
psychological effects of physical conditions, responses to medical treatment, and the
prediction of future symptomatology (Graham, 2011; Marek & Ben-Porath, 2017).
Published in 2008, the MMPI-2-RF has also proven to be a useful aid in health
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psychology assessment. Its scale scores have demonstrated reliability and validity in a
variety of medical contexts, including pre-surgical assessment and monitoring of chronic
pain and epilepsy (Marek & Ben-Porath, 2017). Additionally, the MMPI-2-RF improves
on psychometric limitations of the MMPI-2, such as item overlap between MMPI-2
Clinical scales, which have been eliminated between the Restructured Clinical scales.
However, item overlap has not been entirely eliminated from other MMPI-2-RF scales.
The MMPI instruments may also be used in disability assessment. Social Security
and private disability insurance assessments differ from both personal injury disability
assessment and workers’ compensation disability assessment. Under Social Security and
private disability insurance, a separate assessment for the cause or circumstances that led
to the disability is not made; only a genuine disabling condition must be determined.
Personal injury litigation, however, requires a separate assessment to determine whether
the disability was the fault, whether intentionally or not, of the party being sued.
Workers’ compensation falls in the middle of this continuum as fault does not need to be
demonstrated, but it must be proven that the injury or disability arose due to and in the
course of employment (Lencsis, 1998).
Pollack and Grainey (1984) conducted a study examining group differences in
MMPI scores between state disability insurance applicants, applicants for private
workers’ compensation, and adoption applicants serving as a control group. Significant
differences were found between the three groups, with the adoption group exhibiting the
“best” MMPI scores (i.e., T- scores of approximately 50); however, this group also
demonstrated the highest K scores, indicating attempts to present with low psychological
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disturbance. The private disability applicants scored significantly higher than the
adoption group but lower than the state disability applicants. Overall, this group showed
elevations on scales 1 and 3 with a lower score on scale 2, suggestive of a somatically
focused “conversion V” profile (to be further discussed). The state disability applicants
had very high scores across several MMPI scales with mean scores on scales 1, 2, 3, 4, 6,
7, 8, and 9 ranging from 60.08 to 91.00. This group’s high F scale score in particular (M
= 80.00 for men, M = 77.38 for women) are suggestive of malingering or severe
emotional turmoil. None of these applicants were applying for disability on the basis of
emotional problems; however, emotional problems could still account for these
elevations. Additionally, a need for income from state disability may have provided the
applicants with motivation to appear worse than they truly were. These findings imply
that the three groups examined differ in terms of motivation. With respect to the two
disability applicant groups in particular, it could be expected that on the basis of these
MMPI scores, the private disability applicants would be more likely to be placed in
employment than the state disability applicants (i.e., the state disability applicants would
be more likely to receive monetary compensation on the basis of their injuries).
Traditionally, workers’ compensation required evidence of physical injury
sustained in the workplace. Over time, however, mental conditions became more widely
recognized and deemed acceptable for receiving workers’ compensation, although they
were required to have a physical connection (Drukteinis, 2013). Two types of claims can
be made within these parameters: physical trauma leading to a mental disorder (i.e.,
physical-mental claim) or mental trauma leading to a physical disorder (i.e., mental67

physical claim). In physical-mental claims, a clear precipitating physical injury has
subsequent psychological effects. In mental-physical claims, emotional or stressful
circumstances led to psychological ailments that include objectively assessed physical
concerns. Such emotional or stressful events must have been clearly initially identified as
a discrete event or “nervous shock” (Larson & Larson, 2005, as cited in Drukteinis,
2013).
A third, more controversial, category of claims may also be made. Mental-mental
claims are those in which a mental trauma leads to psychological disorder without any
physical components (Tucker, 2010). These claims are particularly difficult to evaluate,
as verifying personal injury primarily attributed to intangible effects that produce
psychological distress can be problematic. Accidental injury language, on the surface, is
more easily applied to physical, rather than mental or stress, events (Drukteinis, 2013).
Furthermore, as work stress is fairly commonplace today, even when mental-mental
claims are allowed, statutory language is often put in place that requires more than what
is considered the typical amount of stress experienced by all employees in order to
support the claim. Stress experiences and stress claims are also fairly subjective; thus, the
causal connections of the precipitating event(s) and consequences are more likely to be
challenged than those of claims involving a physical component (Lawrence, 1983, as
cited as Drukteinis, 2013). While mental conditions were essentially excluded from
workers’ compensation initially, as mental disorders and their psychological and
physiological bases have become better understood, there has been an increase in
workers’ compensation claims made on these grounds (McDonald & Kulick, 2001, as
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cited in Drukteinis, 2013). Such mental disorders may occur independent of any physical
condition, but they are often comorbid with and complicate physical conditions, as
discussed previously.
Psychological evaluation on the basis of disability claims, whether the disability
be physical, mental, or dual in nature, can be valuable in examining personality factors
contributing to an individual’s symptoms or evaluating an individual’s response to an
acquired physical disability. However, there are limitations in utilizing psychological
assessment measures such as the MMPI instruments in disability evaluations. It is
impossible, for instance, to determine, on the basis of a psychological assessment,
whether a disability claimant’s injuries are organically derived, or if they stem from
personality factors. Furthermore, the nature of an individual’s personality and its
influence on current functioning cannot be established unless personality assessment was
conducted prior to the current disability. In short, there is no foolproof means to detect
prior personality or functioning with only present psychological assessment (Butcher &
Harlow, 1987).
Research with Chronic Health Conditions. Pain patients frequently exhibit a
so-called “conversion V” (or simply “conversion”) profile on the MMPI-2 consisting of
clinically significant high scores (i.e., T ≥ 65) on scales 1 and 3 and a slightly lower score
on scale 2. This profile, also referred to as the “psychosomatic profile,” reflects somatic
concerns as well as disturbances in mood. While this profile is recognized as a likely
accurate report of genuine physical symptoms (Kvåle, Ellertsen, & Skouen, 2001;
Lamping, 1985), it also reflects defensiveness characteristic of a somaticizing patient
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who denies awareness of internal psychological conflict and expresses the conflict via
somatic symptoms and concerns (Ellertsen, Vaeroy, Endersen, & Førre, 1991).
Further investigation into MMPI-2 profiles of a chronic pain sample by Slesinger,
Archer, and Duane (2002) demonstrated that chronic pain patients’ code types were
comparable to the conversion V profile. The most frequent two-point code types for the
chronic pain patients were 1-3/3-1, 2-3/3-2, and 1-2/2-1, respectively. In terms of cluster
types, the neurotic triad profile (i.e., clinically significant high scores on scales 1, 2, and
3, in no particular order) and conversion profile were most frequently observed for
chronic pain patients. Longitudinal studies have shown that high scores on MMPI-2 scale
3 are associated with poor outcomes in chronic low back pain treatment, specifically.
Vendrig (1999) found endorsement of a particular subset of scale 3 items involving
reports of lassitude and malaise (Hy3) was related to failure to return to work after
completing a chronic pain program in the Netherlands. Additionally, high scores on scale
3 predicted continued disability and failure to return to work one year after initial
treatment in a sample of individuals treated for acute low back injury (within six weeks
of the injury). The high scale 3 scores were thought to indicate the injured patients’
development of passive acceptance of disability, and it was concluded that psychosocial
variables associated with high scale 3 scores significantly contributed to the development
of disability resulting from low back injury (Gatchel, Polatin, & Kinney, 1995).
The MMPI-2 PK scale has also been found to be significantly elevated by chronic
pain patients who were victims of motor vehicle accidents (MVA; Duckworth & Iezzi,
2005). Such high scores suggest chronic pain patients who were involved in MVA report
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greater physical injury and impairment, greater psychological distress, and greater use of
maladaptive coping strategies for pain.
Factor analyses of MMPI-2 profiles of chronic pain patients have yielded several
factors specific to this population. Results from a factor analytic study conducted by
Deardorff, Chino, and Scott (1993) demonstrated that four factors emerged for a broad
sample of chronic pain patients (N = 114; chronic low back, head/neck, shoulder/arm,
leg/knee, foot, or multiple site pain), which were labelled as follows: Psychological
Dysfunction (Factor 1), Interpersonal Isolation (Factor 2), Psychomotor Retardation
(Factor 3), and Physical Dysfunction (Factor 4). Factor 1 was found to reflect
psychological distress potentially related to chronic pain as indicated by various
problematic experiences including overall psychological distress (scale F), tension,
anxiety, and conflict (scales 7 and 4), feelings of alienation and mistrust (scales 8 and 6),
and several features of depression (D4, D5, D1, and scale 2). Factor 2 was determined to
represent interpersonal isolation as demonstrated by limited personal resources to manage
stress (negative loading on defensiveness, scale K), pessimism and criticalness (negative
loading on Need for Affection [Hy2]), social anxiety (negative loading on Denial of
Social Anxiety [Hy1]), and positive loading on social introversion (scale 0). Factor 3
reflected psychomotor retardation categorized by low energy (negative loading on scale
9), psychomotor retardation (D2), and inhibited aggression (Hy5). Lastly, Factor 4
represented physical dysfunction, including concern regarding physical functioning (scale
1) and reporting of somatic complaints and physical malfunction (Hy4, scale 3, D3, and
Hy3).
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Vendrig, de Mey, Derksen, and van Akkerveeken (1998) conducted a factor
analytic study inspired by the earlier work of Deardorff et al. (1993) on the MMPI-2
profiles of 248 chronic back pain patients. This study resulted in four similar factors,
renamed Psychological Disturbances (Factor 1), Extraversion-Introversion (Factor 2),
Passivity (Factor 3), and Somatic Complaints (Factor 4). Scales relevant to Factor 1 were
scale 4, scale 6, D5, scale 8, scale 7, D4, and D1. The upper end of Factor 1 reflected
psychological distress including features of depression, feelings of hostility and/or being
mistreated, and internal turmoil, while the lower end indicated the absence of such
distress. Factor 2 scales were K, Hy2, Hy1, and scale 0. The upper end of Factor 2
indicated extraversion, persistence, denial of problems or difficulties, avoidance of
confrontation, and need for affirmation and reassurance. The middle range was indicative
of a healthy balance between positive self-evaluation and self-critique, and the lower end
reflected social isolation, introversion, and an overly critical view of oneself and others.
Factor 3’s scales were D2 and scale 9; the upper range of this factor suggested low
activity levels and a lack of energy, while the lower range was associated with selfassurance, an active and/or outgoing lifestyle, and a sense of involvement. Finally, the
scales of Factor 4 were scale 1, Hy4, D3, and Hy3. The upper range of Factor 4 suggested
the expression of distress via mainly somatic symptoms or complaints, and/or
experiencing distress regarding physical functioning. The lower range of this factor
reflected the absence of such complaints.
Research on use of the MMPI-2-RF among patients with physical health
complaints or documented medical conditions is slowly developing. Tarescavage,
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Scheman, and Ben-Porath (2015) reported on descriptive statistics, reliability
information, and concurrent validity correlations, which may be used to assess and
inform use of the MMPI-2-RF specifically with chronic low back pain patients.
Descriptive findings indicated generally similar scores across gender; however, men
scored higher than women on the BXD, RC4, JCP, SUB, MEC, AGGR-r, and DISC-r
scales, whereas women scored higher on the Fs, FBS-r, GIC, MSF, and AES scales. The
results found for men are not unexpected, as men typically score higher on externalizing
scales than do women, even in the normative sample (Tellegen & Ben-Porath, 2008).
Differences in scores on the Interest scales (i.e., MEC and AES) are also not unusual, as
these scales are comprised of items from MMPI-2 Clinical scale 5, MasculinityFemininity (Ben-Porath, 2012). Women’s higher scores on Symptom Validity (FBS-r)
and Multiple Specific Fears (MSF) remained consistent with normative sample findings,
as well as previous research with other medical populations. For instance, an earlier study
conducted by Tarescavage, Wygant, Boutacoff, and Ben-Porath (2013) indicated that
female bariatric surgery candidates obtained higher scores on FBS-r, HPC, and AES,
while their male counterparts scored higher on BXD, MEC, and DISC-r, and both genders
demonstrated elevations on MLS, reflecting a broad sense of poor health. Tarescavage et
al.’s (2015) finding that women scored higher on Infrequent Somatic Complaints (Fs)
and GIC, however, is less typical for medical samples; this phenomenon is more
commonly found in settings with higher rates of psychopathology (e.g., outpatient
community mental health clinics). Thus, it is fair to say that this sample of chronic low
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back pain patients overall presented with substantial emotional and somatic complaints
on the MMPI-2-RF, consistent with previous research (e.g., Von Korff et al., 2005).
Tarescavage, Scheman, and Ben-Porath (2015) found the MMPI-2-RF Emotional
Dysfunction scales demonstrated several convergent associations with the Pain Disability
Index (PDI; Tait, Chibnall, & Krause, 1990) and the Depression, Anxiety, Stress scales
(DASS; Lovibond & Lovibond, 1996). Findings from the PDI are consistent with the
biopsychosocial model of pain, which states that pain experiences are modulated by
emotions. The Emotional Dysfunction scales most strongly correlated with the DASS
Depression, Stress, and Anxiety scales; however, RCd was most strongly associated with
DASS Depression, not DASS Stress, as might be expected. Instead, the DASS Stress
scale was associated with RC7 and NEGE-r in this sample. Scales from the
Somatic/Cognitive domain demonstrated convergent associations with self-reported and
observed pain, hours resting per day, pain disability, and medication use, but were overall
uncorrelated with observed physical ability. Thus, self-reported pain complaints and
actual physical functioning may not converge because, as suggested by the
biopsychosocial model, pain complaints are influenced by various emotional and
cognitive factors (Gatchel, 2004; Gatchel, Peng, Peters, Fuchs, & Turk, 2007). Generally
speaking, this research indicates that the MMPI-2-RF scale scores are associated with
numerous constructs relevant in the assessment of chronic back pain patients, though
further research is needed.
Research with Disability Compensation Claims. The majority of previous
research regarding the MMPI-2 and disability has primarily focused on the efficacy of
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various Validity scales (i.e., F-K [Gough’s Dissimulation Index; Gough, 1950], Ds2
[Gough’s Dissimulation scale; Gough, 1954], FBS, and Ob [Sum of Obvious Items
Index]), the over-reporting validity scales (specifically, F scales F, Fb, and Fp), and the
Response Bias Scale (RBS) in detecting malingering or feigned symptomatology. For
instance, Chmielewski, Zhu, Burchett, Bury, and Bagby (2017) found the F, Fb, and Fp
scale scores of disability claimants suspected of malingering (N = 54) were significantly
higher than those of non-malingering disability claimants (N = 688). Similarly, Arbisi,
Ben-Porath, and McNulty (2006) determined the over-reporting scales accurately detect
feigned or exaggerated PTSD symptoms within the context of veterans’ compensation
and pension (C&P) evaluations. Bury and Bagby (2002) utilized a similar method in
which the F scales, along with F-K, Ds2, FBS, and Ob, were used to classify malingering
of coached and uncoached PTSD symptoms in a sample of workplace accident victims (N
= 61). Of all validity scales included, the F scales consistently yielded the highest
classification rates for symptom malingering. In both studies, Fp in particular was found
to consistently classify overreporting of symptoms (Arbisi, Ben-Porath, & McNulty,
2006; Bury & Bagby, 2002).
The RBS has been demonstrated to add to the standard MMPI-2 validity scales in
predicting symptom validity test (SVT) failure (i.e., scoring above the cutoff score on the
World Memory Test [WMT], Green, 2003; the Test of Memory Malingering [TOMM],
Tombaugh, 1996; or both) in a sample of personal injury disability claimants. Higher
RBS scores were associated with discriminating between passing or failing SVT (Wygant
et al., 2010). Prior research has also investigated MMPI-2 code types related to disability.
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The results of Livingston, Jennings, Colotla, Reynolds, and Shercliffe’s (2006) study
investigating MMPI-2 code type congruence of injured workers demonstrated two- and
three-point code types very similar to the conversion V profile typical of individuals with
chronic pain (1-2 and 1-2-3, respectively).
Like prior research conducted on the use of the MMPI-2 in the context of
disability compensation, research on the MMPI-2-RF used for the same purpose has
focused primarily on the efficacy of the Validity scales in correctly determining
malingering. For instance, Chmielewski et al. (2017) found the MMPI-2-RF overreporting Validity scales accounted for 35% of the variance in dimensionally assessed
suspected malingering in a sample of disability claimants (N = 742). Among these scales,
the F-r scale demonstrated the greatest predictive power for suspected malingering, along
with Fs. These scales also demonstrated acceptable-to-excellent classification accuracy in
predicting suspected malingering and demonstrated large effect sizes in differentiating
between suspected malingering and non-malingering groups. Similarly, Bianchini et al.
(2017) found highly significant group differences between malingering and nonmalingering pain patients on each MMPI-2-RF Validity scale studied (i.e., F-r, Fb-r, Fs,
FBS-r, and RBS), as well as on two Clinical scales (RCd and RC1). Specifically, the
highest scores on all scales were observed for the group classified as Definite malingered
pain-related disability (MPRD).
Aguerrevere et al. (2018) conducted like research with a sample of financially
incentivized chronic pain patients (N = 348) and found two distinct clusters within this
sample. The first cluster (Cluster 1) demonstrated valid reporting on the MMPI-2-RF,
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with less than 5% of its members exhibiting invalid profiles. The second cluster (Cluster
2) was characterized by mean elevations on all selected overreporting MMPI-2-RF
Validity scales, except Fp-r. Furthermore, MMPI-2-RF profiles were deemed to be likely
invalid due to malingering; almost all members demonstrated elevations (T ≥ 80) on the
Validity scales F-r, RBS, and FBS-r, with approximately 50% of participants presenting
invalid profiles (T ≥ 120) due to highly improbable infrequent responses (F-r) and
negative response bias (RBS). Cluster 1 chronic pain patients also reported significant
elevations on RC scales RC1 and RC2, while Cluster 2 demonstrated elevations on all the
RC scales except for RC3, RC4, and RC9. These elevations were associated with
elevations on the Validity scales, which clearly suggests that the RC scale elevations are
very likely due to symptom exaggeration. This overemphasis on symptoms is directly
captured by each MMPI-2-RF Validity scale meant to detect overreporting. To further
support this statement, description of the Cluster 2 participants specified that
approximately three quarters (71%) of the group were classified as suspected malingerers
according to Bianchini, Greve, and Glynn’s (2005) MPRD criteria. Thus, most Cluster 2
participants were likely presenting invalid MMPI-2-RF profiles due to deliberate efforts
to misrepresent accurate symptomatology in the hopes of possible monetary
compensation.
Tarescavage, Wygant, Gervais, and Ben-Porath (2013) studied the associations
between the five MMPI-2-RF overreporting Validity scales and measures of both effort
(as assessed by neurocognitive measures, such as the Forced Choice Recognition
component of the California Verbal Learning Test-II [CVLT-II; Delis, Kramer, Kaplan,
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& Ober, 2000]) and cognitive SVTs in a sample of non-head injury disability claimants
(N = 863). The MMPI-2-RF overreporting Validity scales were also examined in
comparison with the Slick, Sherman, and Iverson (1999) criteria for malingered
neurocognitive dysfunction (MND). The F-r and RBS scales demonstrated significantly
stronger associations with SVT scores than did the remaining MMPI-2-RF overreporting
Validity scales. The MMPI-2-RF Validity scales also did well in differentiating between
MND participant groups. In particular, RBS exhibited the largest effect size in
differentiating between the Incentive Only and Probable/Definite MND groups. RBS also
displayed the best sensitivity for detecting MND at cutoffs with a false positive rate of
10%.
When patients present evidence of MND, they respond to self-report measures in
such a way that reflects the experience of great emotional distress and interpersonal
avoidance along with various somatic symptoms and cognitive complaints. Furthermore,
as patients display probable or definite evidence of MND, they may endorse MMPI-2-RF
items that suggest thought dysfunction. Tarescavage et al. (2013) found that patients with
Probable/Definite MND (i.e., those who had an external incentive, such as involvement
in a personal injury or disability claim, and exhibited below chance performance on at
least one cognitive SVT) generally scored higher on the RC2 and RCd scales than
patients whose MND was Suspect or Probable (i.e., those who had an external incentive
and scored below cutoff, but not below chance on one cognitive SVT, and those who had
an external incentive and scored below cutoff, but not below chance on at least two
cognitive SVTs or performed below cutoff on one cognitive SVT and below cutoff on an
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embedded indicator of effort [e.g., Reliable Digit Span], respectfully) or who were purely
externally incentivized (i.e., Incentive Only). Earlier research (e.g., Gervais, Wygant,
Sellbom, & Ben-Porath, 2011; Thomas & Youngjohn, 2009) has examined similar effects
in disability claimants who failed at least one cognitive SVT and a sample of traumatic
brain injury (TBI) litigants, respectfully. Gervais et al. (2011) found that disability
claimants with SVT failure had high scores on scales RC1, RCd, and RC2, and averaged
near clinical elevation on scale RC6. Thomas and Youngjohn (2009) obtained similar
results in a sample of TBI litigants (N = 83), with those who demonstrated poor effort on
cognitive SVTs also having elevated scores on RC1 and RC2, accompanied by near
clinical elevations on RC8 and RCd.
Previous MMPI-2-RF and disability compensation research has also focused
specifically on the accuracy of the RBS in detecting malingering. Wygant et al. (2010)
examined the ability of the RBS to predict SVT failure in a sample of personal injury and
disability claimants (N = 127) and obtained comparable results to the initial RBS
validation sample studied by Gervais, Ben-Porath, Wygant, and Green (2007), wherein
the RBS outperformed the F scales and FBS in classifying SVT performance. Wygant et
al. (2010) found that the RBS added to the standard MMPI-2 and MMPI-2-RF Validity
scales in predicting SVT failure in that sample of personal injury and disability claimants.
Their research also supports the notion that symptom exaggeration in the context of
disability is more likely to take the form of overreported physical, rather than
psychological, symptoms, consistent with individuals presenting themselves as being
injured.
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Rationale and Hypotheses
The examination of psychological factors involved in or co-occurring with
physical conditions is often useful. Chronic health conditions, both physical and mental,
have more recently become a major concern; patients in mental healthcare settings have
increasingly presented with chronic physical conditions and patients in primary care
settings often report or have underlying emotional and/or behavioral concerns.
Approximately 30% of Americans have a diagnosable psychiatric disorder at any given
point in time, and roughly 50% will experience a diagnosable disorder at some point in
their lives (Kessler et al., 2005a; Kessler et al., 2005b). The United States population was
313.9 million in 2016; therefore, it can be said that hundreds of millions of Americans
have been, are, or will be affected by mental illness (Robinson & Reiter, 2016).
Similarly, the number of individuals receiving disability compensation has increased
substantially from 6,673,362 in 2000 to 10,162,488 in 2018 (Social Security
Administration, 2018). Thus, these two areas deserve particular focus.
Personality assessment has aided in identifying important aspects of personality
that contribute to and result from health conditions. This area of study was enhanced by
the development of the MMPI as a great deal of research on the original MMPI involved
various medical patient samples. Substantial research has been conducted with the
MMPI-2 in these regards, largely relating to chronic pain. However, it has not focused on
a broader scope of medical conditions such as hepatitis, Lyme disease, cancer, and
fibromyalgia, and these conditions’ impacts on psychological functioning. These and
other physical health conditions can have an adverse impact on emotional and behavioral
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functioning. The existing MMPI literature has focused largely on within-group
differences to identify distinct personality patterns of subgroups with various medical
conditions. When between-group comparisons have occurred, for example, between
malingering and nonmalingering disability claimants, they have focused on the use of
Validity scales to identify malingering (e.g., Chmielewski et al., 2017). In general, less
attention has been given to between-group differences in MMPI-based research of health
related conditions. Moreover, no study to date has specifically compared MMPI
instrument profiles of individuals with comorbid physical and mental health complaints,
those seeking or receiving Social Security disability compensation, and those presenting
with purely psychological difficulties. While some overlaps of personality patterns may
be expected between individuals with comorbid chronic health conditions and those
involved in disability or personal injury litigation, particularly in terms of somatic
indices, important differences may need to be identified. Therefore, these were a central
focus of the current study.
While a fair amount of MMPI-2 research in medical and healthcare settings has
been undertaken, this area of research is in its infancy for the MMPI-2-RF, given that it is
the most recent of this family of instruments. Furthermore, as the MMPI-2-RF is a
substantially different restructured test, there is relatively limited generalizability from
the older forms of the instrument and a new research literature with this measure is
needed. Specifically, because the MMPI-2-RF is a 21st century addition to the family of
MMPI instruments at a time when healthcare is a considerable national interest, this

81

particular area of research is likely to be valuable. The current study thus contributes to
this developing literature.
The current study examined differences in the MMPI-2-RF profiles of outpatients
receiving services at a community mental health clinic on the bases of (a) reported
comorbid physical and psychological conditions, (b) reported receiving or seeking of
Social Security disability compensation, and (c) purely psychological complaints. Based
on prior research findings with the MMPI and MMPI-2, persons with comorbid physical
and psychological conditions were expected to demonstrate a mixed profile punctuated
with somatic complaints but also evidence various psychological components. Those
seeking disability compensation were expected to demonstrate similar but more
pronounced high-score profiles in terms of physiological and psychological concerns.
Individuals with purely psychological complaints may also display somatic expressions
(e.g., related to somaticizing psychological symptoms), but other areas of psychological
difficulty were likely to be prominent. Thus, some similarities were expected across the
three groups in somatic, emotional, and behavioral expressions. However, the central
goal of this study was to examine specific areas of difference. Because this topic has not
been previously researched, this objective was undertaken in an exploratory manner.
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Method
Participants
The initial sample pool for this study consisted of 377 adult clients who had received
services from a university-affiliated community mental health clinic in the Southeastern
United States. This sample was reduced to 154 participants on the bases of (a) invalid
MMPI-2-RF profiles, (b) age, and (c) reduction of the psychological complaints group to
equate its size with those of the other groups of this study. Inclusion criteria based on
patients’ MMPI-2-RF profiles consisted of the following: Item omissions < 15, VRIN-r
and TRIN-r T- scores < 80, L-r scale T- score < 80, K-r scale T-score < 70, F-r T-scores <
120, and Fp-r, Fs, and FBS-r T- scores < 100. Application of these criteria ensures the
test profiles are not invalidated by insufficient responding, inconsistent and/or biased
responding, excessively favorable self-presentation, excessive defensiveness, or
unrealistically high over-reporting of symptoms (Ben-Porath & Tellegen, 2008). Use of
the MMPI-2-RF score criteria resulted in the exclusion of 39 participants.
The final sample (N = 154) was divided into three groups based on whether they had
comorbid physical and psychological complaints (n = 66), were receiving or seeking
Social Security disability compensation (n = 30), or sought services for purely
psychological ailments (n = 58). The groups were defined in the following manner: (a)
Participants in the comorbid complaints group must have reported a chronic medical
condition (e.g., diabetes, cancer, multiple sclerosis) at the time of intake, in addition to
seeking treatment for psychological concerns, (b) those in the Social Security disability
compensation group must have reported either receiving or being in the process of
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applying for Social Security disability compensation on the basis of a psychological
and/or medical condition at the time of intake, and (c) participants in the psychological
complaints group must have presented only with ailments related to or symptoms of
psychological disorder. Table 2 presents the psychological diagnoses of all three groups.

(continues)
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Table 2
Psychological diagnoses of the total sample (N = 154) by group
Diagnostic Category
Comorbid
Complaints (n = 66)

Social Security Disability
Compensation (n = 30)

Psychological
Complaints (n = 58)

Frequency
14

%
21.2

Frequency
3

%
10.0

Frequency
22

%
37.9

13

19.7

7

23.3

11

19.0

Anxiety or Related Disorder

7

10.6

0

0

1

1.7

Substance-Related Disorder

3

4.5

0

0

4

6.9

Trauma/Stress-Related
Disorder
Personality Disorder

8

12.1

0

0

4

6.9

1

1.5

1

3.3

0

0

Schizophrenia/Psychosis

1

1.5

2

6.7

0

0

Developmental Disorder

1

1.5

3

10.0

0

0

Two or More Psychological
Disorders
Other (e.g., Pain Disorder)

12

18.2

10

33.3

16

27.6

6

9.1

2

6.7

0

0

Diagnostic Information Not
Available

0

0

2

6.7

0

0

Co-occurring SubstanceRelated and Psychological
Disorders
Depression/Mood Disorder
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Within the comorbid complaints group (n = 66), 44 participants (66.7%) were
women and 22 (33.3%) were men. Ages of the individuals in this sample ranged from 18
years to 82 years with a mean age of 44.50 (SD = 15.55). In terms of ethnic distribution,
89.4% of the comorbid complaints sample identified as White/Caucasian, 4.5% as
Black/African-American, 3.0% as Hispanic, and 3.0% as Bi-or Multiracial/Other.
The individuals in the comorbid conditions group presented with a wide range of both
medical and psychiatric diagnoses. Table 3 presents data on the reported medical
diagnoses of this group.
Table 3
Medical diagnoses reported by the comorbid complaints group (n = 66)
Diagnostic Category
Chronic Pain/Pain-Related (e.g., Fibromyalgia)

Frequency
16

%
24.2

Chronic Infection (e.g., Hepatitis C)

4

6.1

Diabetes/Endocrine Disorder

2

3.0

Asthma/Chronic Obstructive Pulmonary Disease (COPD)

3

4.5

Gastrointestinal Disorder (e.g., Irritable Bowel Syndrome
[IBS])
Cancer

3

4.5

3

4.5

Thyroid/Hormonal Disorder (e.g., Hashimoto’s Disease)

3

4.5

Movement Disorder (e.g., Cerebral Palsy)

1

1.5

Multiple Diagnoses

23

34.8

Other (e.g., Sleep Apnea)

8

12.1

Within the Social Security disability compensation group (n = 30), 15 participants
were men (50.0%) and 15 were women (50.0%). Ages of this group ranged from 18 years
to 63 years with a mean age of 40.43 (SD = 14.01). With respect to race/ethnicity, 80.0%
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of the Social Security disability compensation group identified as White/Caucasian,
10.0% as Black/African-American, 3.3% as Hispanic, and 3.3% as Bi- or
Multiracial/Other. Race/ethnicity was not identified for one (3.3%) participant in the
Social Security disability compensation group. Table 4 presents the medical diagnoses of
this group and Table 5 displays data on the justification provided by participants in this
group for seeking or receiving Social Security disability compensation.
Table 4
Medical diagnoses reported by the Social Security disability compensation group (n =
30)
Diagnostic Category
Chronic Pain/Pain-Related (e.g., Fibromyalgia)

Frequency
5

%
16.7

Chronic Infection

1

3.3

Neurological Disorder (e.g., Epilepsy)

2

6.7

Multiple Diagnoses

8

26.7

No Diagnosis

11

36.7

Diagnostic Information Not Available

3

10.0

Table 5
Reason for seeking or receiving Social Security disability compensation as reported by
the group (n = 30)
Reason for Seeking/Receiving Social
Security Disability Compensation
Physical

Frequency

%

7

23.3

Psychological

13

43.3

Physical and Psychological

2

6.7

Unclear/Not Specified

8

26.7

Lastly, within the purely psychological complaints group (n = 58), 31 participants
were men (53.4%) and 27 were women (46.6%). Ages of this group ranged from 18 years
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to 64 years with a mean age of 35.97 (SD = 12.66). In terms of race/ethnicity, 87.9% of
the psychological complaints group identified as White/Caucasian, 6.9% as Hispanic,
1.7% as Asian, and 3.4% as Bi-or Multiracial/Other.
Measures
The central measure of this study was the MMPI-2-RF. Forty-nine of the 51
scales, excluding the Interest scales (which were deemed not relevant to this study), were
examined. The MMPI-2-RF Technical Manual (Tellegen & Ben-Porath, 2008) details
support of the MMPI-2-RF’s psychometric accuracy. The MMPI-2-RF’s psychometric
properties were assessed using existing MMPI-2 datasets, and its Technical Manual
provides reliability coefficients and Standard Error of Measurement (SEM) values for the
Validity and Substantive scales for the normative sample, an outpatient community
mental health sample, a psychiatric inpatient sample from a general community hospital,
and male Veteran Administration’s hospital inpatients (Tellegen & Ben-Porath, 2008).
The Technical Manual provides test-retest reliability values for the normative
sample and the clinical samples. The Validity scales test-retest reliability coefficients and
SEMs ranged from .40/8 for TRIN-r to .84/4 for K-r. TRIN-r and VRIN-r have higher
SEMs and lower test-retest reliability values, which Tellegen and Ben-Porath (2008)
posit is due to these scales’ natures, as they assess response style. The H-O and RC scales
each demonstrated strong test-retest reliability and SEMs, with H-O coefficients and
SEMs ranging from .71/5 for THD and .91/3 for BXD and RC coefficients and SEMs
ranging from .64/6 for RC6 and .89/3 for RC4. The Specific Problems scales
demonstrated adequate reliability with coefficients ranging from .54 for NUC to .92 for
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MEC. The Somatic/Cognitive scales in particular demonstrated lower reliability
coefficients than the other categories of the Specific Problems scales. The SEMs for this
grouping of scales were also adequate, ranging from 7 for NUC to 3 for MEC. Finally,
the PSY-5 scales demonstrated strong test-retest reliability with coefficients and SEMs
ranging from .76/5 for PSYC-r and .93/3 for DISC-r. Overall, these internal consistency
values demonstrate support for the stability of MMPI-2-RF scores (Tellegen & BenPorath, 2008).
As the outpatient community mental health reference sample (410 men, 610
women) best matches the sample of this study, the internal consistency values for that
group are reported here. The internal consistency values for the Validity scales ranged
from .24 for VRIN-r (women) to .85 for F-r (both men and women). The internal
consistency values of the H-O and RC scales ranged from .77 for RC4 (women) to .96 for
EID (men). Internal consistency values for the Somatic/Cognitive and Internalizing scales
ranged from .48 for BRF (men) to .83 for COG (women). The Externalizing,
Interpersonal, and Interest scales’ internal consistency values ranged from .55 for MEC
(women) to .85 for SAV (women). Lastly, the internal consistency values of the PSY-5
scales range from .70 for DISC-r (women) to .85 for INTR-r (men). Overall, these values
indicate the MMPI-2-RF demonstrates adequate internal consistency reliability (Tellegen
& Ben-Porath, 2008).
External validity data for the MMPI-2-RF has been collected from a variety of
settings in which this instrument is likely to be used, demonstrating the convergent and
discriminant validity of the test’s scores. These data provide support for the construct
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validity of the substantive scales. According to Tellegen and Ben-Porath (2008), the
empirical correlates described in the Technical Manual also provide the basis for
meaningful interpretation of the MMPI-2-RF. These external correlates, along with the
additional psychometric findings detailed in the Technical Manual, provide support for
the ability of the MMPI-2-RF to demonstrate the appropriate level of validity with
respect to assessing responses and characteristics of personality and psychological
dysfunction (Tellegen & Ben-Porath, 2008).
Procedure
The study began upon approval from the Florida Institute of Technology
Institutional Review Board (IRB), the clinic from which data was collected, and the
Doctoral Research Project committee. Participants’ demographic information (i.e., age,
race/ethnicity, and gender) and MMPI-2 scores was extracted from the clinic’s electronic
client records, spanning approximately five years (i.e., 2014-2019). Because the
participants had been tested with the MMPI-2, their MMPI-2 item responses were used to
derive MMPI-2-RF scores with the use of computerized scoring software. This approach
is supported by research that has demonstrated MMPI-2-RF scores derived from the
MMPI-2 are comparable to scores obtained from the MMPI-2-RF alone (Van der
Heijden, Egger, & Derksen, 2010). All data was input into an SPSS database. Client
identities were protected in that personally identifying information was not included in
the research database. Instead, participants were assigned ID numbers in place of names.
As mentioned previously, the sample of this study initially consisted of 377
participants. After the initial participant groups were formed, their MMPI-2 profiles were
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rescored as MMPI-2-RF profiles via the use of computer software or hand-scoring
templates. Following this procedure, the validity of all MMPI-2-RF profiles was assessed
in accordance with the inclusion criteria. Seven of the 73 initial comorbid complaints
group profiles were removed, one due to a TRIN-r T-score of 80, one due to a L-r T-score
> 80, two due to F-r T-scores of 120, two due to Fs T-scores > 100, and one due to an
FBS-r T-score > 100, which resulted in a final comorbid complaints group of n = 66.
Twenty out of the 51 initial Social Security disability compensation profiles were
excluded, one due to a VRIN-r T-score > 80, one due to a L-r T-score > 80 and Fp-r Tscore of 120, two due to Fp-r T-scores > 100, one due to an FBS-r T-score > 100, two
due to an Fs T-score > 100, one due to Fs and FBS-r T-scores > 100, and 12 due to F-r Tscores of 120. An additional case was removed from this group on the basis of age: one
participant was 17 years old, and thus did not meet the inclusion criteria of being an adult
client. The final Social Security disability compensation group was formed at n = 30.
Lastly, 12 of the 253 initial psychological complaints profiles were removed, one due to a
VRIN-r T-score > 80, two due to TRIN-r T-scores ³ 80, one due to a TRIN-r T-score ³ 80
and an L-r T-score > 80, two due to L-r T-scores > 80 alone, one due to a L-r T-score >
80 and a K-r T-score > 70, two due to Fs T-scores > 100, two due to Fp-r T-scores >100,
and one due to a F-r T-score of 120. At this stage, the psychological complaints group
was n = 241.
Following the removal of all invalid profiles, focused reduction of the
psychological complaints group using age (specifically, ages 18, 21, and 23 years) was
undertaken in order to establish a sample size and age composition more comparable to
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the larger of the other two participant groups, which was the comorbid complaints
subsample. The ages 18, 21, and 23 were selected because they occurred in the highest
frequency in the psychological complaints group. The original counts of participants of
these ages in this subsample were as follows: age 18 n = 13, age 21 n = 13, and age 23 n
= 12. A total of 30 profiles, ten from each age, were removed. A random number
generator was used to select each profile to be removed; every second profile was
removed until 10 profiles from each age were removed, resulting in three remaining 18year olds, three 21-year-olds, and two 23-year-olds. After this procedure, the
psychological complaints group was comprised of 211 individuals overall. A second
focused reduction involved removing all cases (n = 40) for which diagnostic information
was not available, leaving 171 participants in the psychological complaints group. Lastly,
a random number generator was again utilized to further reduce this subsample, such that
every fifth profile was removed until the final psychological complaints group was n =
58.
Data Analyses
Preliminary analyses consisted of use of descriptive statistics (e.g., means,
standard deviations, percentage data) to describe the demographic characteristics of each
of the three subsamples used in the study. Central analyses consisted of a multivariate
analysis of variance (MANOVA) comparing MMPI-2-RF scale scores across each of the
three groups, followed by univariate analyses of variance (ANOVA) to examine specific
areas of significant difference. The Bonferroni post hoc test was used for identification of
specific scales whose scores differed significantly between groups. After scales
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contributing to significant differences between groups were identified, hierarchical and
simple linear regression analyses were used to determine which of these scales were most
predictive of between-group variance.
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Results
Initial analyses consisted of computing the means and standard deviations for
scaled scores for the MMPI-2-RF for each of the three participant groups. Table 5
displays these scores.

(continues)
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Table 6
MMPI-2-RF T-score means and standard deviations for the total sample (N = 154) by group
MMPI-2-RF Scale

Comorbid
Complaints (n = 66)
________________
M
SD

Social Security Disability
Compensation (n = 30)
___________________
M
SD

Psychological
Complaints (n = 58)
________________
M
SD
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Validity Scales
Cannot Say (?)

0.41

1.64

0.27

1.11

0.07

0.26

Variable Response Inconsistency (VRIN-r)

54.23

9.74

51.90

9.02

51.09

9.56

True Response Inconsistency (TRIN-r)

57.30

7.19

58.33

7.03

55.33

5.66

Infrequent Responses (F-r)

71.79

19.15

79.40

19.39

70.24

19.04

Infrequent Psychopathology Responses (Fp-r)

58.17

12.80

62.93

15.11

59.69

16.70

Infrequent Somatic Responses (Fs)

62.42

16.13

70.07

17.30

63.57

15.54

Symptom Validity (FBS-r)

68.45

15.19

70.67

13.66

64.95

14.45

Uncommon Virtues (L-r)

51.36

10.17

56.47

8.70

50.93

9.20

Adjustment Validity (K-r)

44.26

8.96

40.63

10.30

43.02

9.93

(table continues)

Table 6 (cont.)
MMPI-2-RF T-score means and standard deviations for the total sample (N = 154) by group
MMPI-2-RF Scale

Comorbid
Complaints (n = 66)

Social Security Disability
Compensation (n = 30)

Psychological
Complaints (n = 58)

M

SD

M

SD

M

SD

Emotional/Internalizing Dysfunction (EID)

65.58

12.79

70.10

12.98

65.81

13.64

Thought Dysfunction (THD)

54.89

12.17

55.27

11.14

52.09

10.57

Behavioral/Externalizing Dysfunction
(BXD)
Restructured Clinical (RC) Scales

52.48

11.96

53.43

11.76

55.95

11.06

Demoralization (RCd)

65.79

12.47

70.10

10.29

67.79

12.38

Somatic Complaints (RC1)

65.36

14.01

69.37

13.80

60.88

13.76

Low Positive Emotionality (RC2)

64.83

15.86

74.87

14.04

63.29

15.47

Cynicism (RC3)

51.56

9.86

56.13

11.58

53.90

10.94

Antisocial Behaviors (RC4)

58.18

11.14

57.30

11.15

60.50

10.90

Ideas of Persecution (RC6)

58.55

12.88

58.07

11.66

57.50

13.04

Higher-Order (H-O) Scales
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Table 6 (cont.)
MMPI-2-RF T-score means and standard deviations for the total sample (N = 154) by group
MMPI-2-RF Scale

Comorbid Complaints
(n = 66)

Social Security Disability
Compensation (n = 30)

Psychological
Complaints (n = 58)
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M

SD

M

SD

M

SD

Dysfunctional Negative Emotions (RC7)

59.97

11.95

59.23

12.33

57.95

13.17

Aberrant Experiences (RC8)

56.45

11.80

57.50

12.78

53.29

10.88

Hypomanic Activation (RC9)

46.56

8.90

48.23

10.94

50.07

10.22

Malaise (MLS)

66.67

13.22

75.27

12.51

65.90

12.76

Gastrointestinal Complaints (GIC)

63.21

17.19

66.60

15.89

63.62

16.73

Head Pain Complaints (HPC)

61.71

13.80

63.97

12.99

58.40

13.16

Neurological Complaints (NUC)

62.64

14.45

68.93

14.05

58.21

12.63

Cognitive Complaints (COG)

65.39

15.10

70.97

14.82

63.71

13.31

Specific Problem Scales
Somatic/Cognitive Scales

(table continues)

Table 6 (cont.)
MMPI-2-RF T-score means and standard deviations for the total sample (N = 154) by group
MMPI-2-RF Scale

Comorbid Complaints
(n = 66)

Social Security Disability
Compensation (n = 30)

Psychological
Complaints (n = 58)

M

SD

M

SD

M

SD

Suicidal/Death Ideation (SUI)

56.06

14.58

52.70

14.16

55.26

15.54

Helplessness/Hopelessness (HLP)

57.41

15.43

63.87

17.29

58.91

15.39

Self-Doubt (SFD)

62.88

13.00

65.10

10.41

64.14

13.28

Inefficacy (NFC)

60.85

12.75

60.47

11.88

60.67

12.20

Stress/Worry (STW)

60.92

12.17

59.13

11.75

58.24

10.84

Anxiety (AXY)

67.83

15.16

63.30

15.31

62.05

15.41

Anger Proneness (ANP)

54.35

11.48

57.97

14.69

56.52

13.44

Behavior-Restricting Fears (BRF)

56.47

12.92

56.20

11.03

52.16

10.44

Multiple Specific Fears (MSF)

49.83

7.69

49.53

10.12

46.81

9.16

Internalizing Scales
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Table 6 (cont.)
MMPI-2-RF T-score means and standard deviations for the total sample (N = 154) by group
MMPI-2-RF Scale

Comorbid Complaints
(n = 66)
___________________

Social Security Disability
Compensation (n = 30)

Psychological
Complaints (n = 58)
___________________

M

SD

M

SD

M

SD

Juvenile Conduct Problems (JCP)

55.79

13.46

56.73

13.58

54.31

12.37

Substance Abuse (SUB)

54.97

13.37

52.20

10.02

60.76

14.29

Aggression (AGG)

50.89

9.19

52.80

10.96

53.38

12.53

Activation (ACT)

47.26

9.52

49.03

11.76

48.97

10.29

Family Problems (FML)

57.20

12.25

56.93

11.97

57.62

11.65

Interpersonal Passivity (IPP)

52.82

13.10

51.93

9.48

49.74

7.64

Social Avoidance (SAV)

60.09

13.99

59.50

13.33

56.93

14.04

Shyness (SHY)

54.88

12.64

52.93

9.85

52.33

11.21

Disaffiliativeness (DSF)

56.73

14.50

60.67

15.92

56.52

15.54

Externalizing Scales
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Interpersonal Scales

(table continues)

Table 6 (cont.)
MMPI-2-RF T-score means and standard deviations for the total sample (N = 154) by group
Comorbid
Complaints (n = 66)
________________

Social Security Disability
Psychological
Compensation (n = 30)
Complaints (n = 58)
________________
__________________

M

SD

M

SD

M

SD

Aesthetic-Literary Interests (AES)

47.08

10.10

40.03

7.63

47.97

10.95

Mechanical-Physical Interests (MEC)

48.05

9.19

49.13

10.82

48.74

9.37

Personality Psychopathology Five (PSY5) Scales
Aggressiveness-Revised (AGG-r)

47.59

11.24

47.70

9.52

49.28

9.48

Psychoticism-Revised (PSYC-r)

54.77

12.90

56.50

10.55

51.91

10.88

Disconstraint-Revised (DISC-r)

51.50

11.95

52.17

10.54

55.24

10.42

Negative Emotionality-Revised (NEGE-r)

60.79

11.98

61.60

14.10

59.57

12.30

Interest Scales*
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Introversion/Low Positive Emotionality62.55
14.73
67.53
15.55
60.35
14.60
Revised (INTR-r)
Note. Mean scores in boldface represent 1 SD above the normative mean of 50 or higher (³60). *Interest scale scores
were not used in this study’s analysis.

The comorbid complaints group had mean T-scores ³ 60 (i.e., high scores) for 19
(39%) of the 49 MMPI-2-RF scales included in the analysis. Specifically, all of the
Specific Problems Somatic/Cognitive scales and Somatic Complaints (RC1) had high
scores. Among those scales measuring aspects of emotionality, Emotional/Internalizing
Dysfunction (EID), Demoralization (RCd), Low Positive Emotionality (RC2), Self-Doubt
(SFD), Inefficacy (NFC), Anxiety (AXY), Negative Emotionality-Revised (NEGE-r), and
Introversion/Low Positive Emotionality-Revised (INTR-r) were each at a T-score of 60 or
greater. In addition, the comorbid complaints subsample demonstrated high mean scores
on Social Avoidance (SAV) and Stress/Worry (STW). Among the Validity scales, this
group’s scores on Infrequent Responses (F-r), Infrequent Somatic Responses (Fs), and
Symptom Validity (FBS-r) were at T ³ 60.
The mean T-scores of the Social Security disability compensation group were ³
60 for 20 (41%) of the 49 scales. A pattern of high scores similar to that of the comorbid
complaints group emerged for Emotional/Internalizing Dysfunction (EID), and select RC
scales, Somatic/Cognitive scales, Internalizing scales, and PSY-5 scales. In addition, this
group demonstrated high scores on Helplessness/Hopelessness (HLP) and
Disaffiliativeness (DSF). The Social Security disability compensation group displayed
the same Validity scales high scores as the comorbid complaints group with the addition
of a high score on Infrequent Psychopathology Responses (Fp-r) as well.
The psychological complaints group had mean T-scores ³ 60 for 16 (33%) of the
49 scales in a pattern similar to those of the other two groups; for instance, this group’s
mean high scores on the H-O, RC, and Internalizing scales approximated those of the
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comorbid complaints and Social Security disability compensation groups. This group
demonstrated fewer mean high scores on the Somatic/Cognitive scales than the other two
groups (specifically, mean T-scores were ³ 60 on Malaise [MLS], Gastrointestinal
Complaints [GIC], and Cognitive Complaints [COG]) and no elevations on any of the
Interpersonal scales. However, this group was the only group to demonstrate mean high
scores on Antisocial Behaviors (RC4) and one Externalizing scale, Substance Abuse
(SUB). The high Validity scale scores of the psychological complaints group were the
same as those of the comorbid complaints group (i.e., Infrequent Responses [F-r],
Infrequent Somatic Responses [Fs], and Symptom Validity [FBS-r]).
Several trends emerged for all three groups’ MMPI-2-RF scale scores. First,
scores on several scales related to internalization of emotions and negative emotionality
(i.e., EID, RCd, RC2, SFD, NFC, AXY, and INTR-r) were at T ³ 60 for all three groups.
Each group also exhibited high scores on some scales assessing somatic and cognitive
symptoms (i.e., RC1, MLS, GIC, and COG) and some Validity scales (i.e., F-r, Fs, and
FBS-r). This resulted in a total of 14 scales on which each group demonstrated scores at
T ³ 60.
In terms of distinct trends of each group, the Social Security disability
compensation group alone had high mean T-scores on Fp-r, HLP and DSF. Only the
comorbid complaints group produced a mean T-score ³ 60 on STW and SAV and the
psychological complaints group alone produced high mean T-scores on RC4 and SUB. As
an additional step, the overall mean score for the 14 scales on which all three groups
demonstrated high scores was computed separately for each group. The overall mean
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high score of the Social Security disability compensation group was 69.56, that of the
comorbid complaints group was 65.26, and that of the psychological complaints group
was 64.07. Thus, the mean score was higher by approximately one-half standard
deviation for the Social Security disability compensation group than for the other two
groups, and was roughly two standard deviations higher than the normative mean for the
MMPI-2-RF.
The central analyses of this study consisted of assessing significant differences in
MMPI-2-RF scale scores across the three groups. A MANOVA was conducted for this
purpose. It should be noted that a significant Box’s M test (p = .001) indicated covariance
matrices of MMPI-2-RF scale scores across groups were not homogeneous (i.e., the
observed covariance of MMPI-2-RF scale scores was not equal across the three
participant groups). However, the MANOVA is robust to violations of the assumption of
homogeneity of covariance matrices. Moreover, the assumption of sphericity was met,
that is, Bartlett’s test of sphericity was significant (p < .01), which indicated the study
group variances can be assumed to be equal. These findings supported analysis of the
MANOVA results. The MANOVA result was significant, Wilks’ l = .32, p < .01, partial

h! = .44. Subsequent univariate ANOVA results were examined to determine significant
differences in MMPI-2-RF scale scores across the three groups; these results are
presented in Table 7.
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Table 7
Significantly different MMPI-2-RF scale scores across the comorbid complaints, Social
Security disability, and psychological complaints groups (N = 154)
Scale
L-r

df
2

F
3.77

p
.025

partial h!
.048

RC1

2

3.95

.021

.050

RC2

2

6.06

.003

.074

MLS

2

5.87

.004

.072

NUC

2

6.11

.003

.075

SUB

2

5.08

.007

.063

Note. These results refer to significant differences between any pair of groups among the
three study groups, and are not necessarily representative of every combination of pairs.
Two patterns can be discerned when observing the significant differences in scale
scores across the three participant groups. First, three of these six scales were also among
those on which each group demonstrated high scores of T ³ 60 (i.e., RC1, RC2, and
MLS). However, three additional scales whose scores were not necessarily in the T ³ 60
range for each group also emerged as being significantly different across groups (i.e., L-r,
NUC, and SUB).
Following the ANOVA, subsequent Bonferroni post-hoc analyses were conducted
to determine significant differences in MMPI-2-RF scale scores between specific pairs of
this study’s participant groups; that is, between the comorbid complaints and Social
Security disability compensation groups, between the comorbid complaints and
psychological complaints groups, and between the Social Security disability
compensation and psychological complaints groups. Significant differences were found
between the comorbid complaints and Social Security disability compensation groups,
between the Social Security disability compensation and psychological complaints
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groups, and between the comorbid and psychological complaints groups. Table 8 presents
significant differences on MMPI-2-RF scores between the Social Security disability
compensation and comorbid complaints groups, while Table 9 displays significant score
differences between the Social Security disability compensation and psychological
complaints groups.
Table 8
Significantly different MMPI-2-RF scale scores of the Social Security disability
compensation (n = 30) and comorbid complaints (n = 66) groups
Scale

RC2

Social Security
Disability Compensation
____________________
M
SD
74.87
14.04

Comorbid
Complaints
_________________
M
SD
64.83
15.86

Mean
Difference

p

10.03

.011

MLS

75.27

12.51

66.67

13.22

8.60

.009

L-r

56.47

8.70

51.36

10.17

5.10

.049

Note. Mean difference in boldface indicates mean difference ³ 1 SD from the normative
mean.
As seen in Table 8, significant differences in MMPI-2-RF scale scores between
the Social Security disability compensation and comorbid complaints groups were
observed for only three of the 49 scales of interest. Mean scores for these three scales
were consistently higher for the Social Security disability compensation group than for
the comorbid complaints group. As indicated above, RC2 produced the largest difference
between the Social Security disability compensation and comorbid complaints groups.
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Table 9
Significantly different MMPI-2-RF scale scores of the Social Security disability
compensation (n = 30) and psychological complaints (n = 58) groups
Scale

RC2

Social Security Disability
Psychological
Compensation
Complaints
____________________ __________________
M
SD
M
SD
74.87
14.04
63.29
15.47

Mean
Difference

p

11.57

.003

NUC

68.93

14.05

58.21

12.63

10.73

.002

MLS

75.27

12.51

65.90

12.76

9.37

.005

SUB

52.20

10.02

60.76

14.29

8.56*

.013

RC1

69.37

13.80

60.88

13.76

8.49

.022

L-r

56.47

8.70

50.93

9.20

5.54

.033

Note. Mean differences in boldface indicate mean differences ³ 1 SD from the normative
mean. * denotes the mean high score of the psychological complaints group was greater
than that of the Social Security disability compensation group.
Among the six scales that had significantly different scores between the groups
shown in Table 9, mean scores were generally higher for the Social Security disability
compensation group than the psychological complaints group; however, the
psychological complaints group scored higher than the Social Security disability
compensation group on SUB. RC2 and NUC were found to have the greatest difference
between the Social Security Disability compensation and psychological complaints
groups.
SUB was the only scale that significantly differed between the psychological
complaints and comorbid complaints group, with the psychological complaints group
demonstrating a higher score (M = 60.76, SD = 14.29) than the comorbid complaints
group (M = 54.97, SD = 13.37). The mean difference of these scores was 5.79, p = .047
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Hierarchical linear regression analyses were conducted to determine which of the
above-noted scales had the greatest explanatory power in distinguishing between the
Social Security disability compensation group and the comorbid complaints group and
between the Social Security disability group and the psychological complaints group. The
three MMPI-2-RF scales identified as differing significantly between the Social Security
disability compensation group and the comorbid complaints group were entered into the
first regression analysis based on the size of their mean differences in descending order as
follows: RC2, MLS, and L-r. Results of this analysis indicated that collectively, these
three scales collectively accounted for 13% of the variance in score differences between
the Social Security disability compensation and comorbid complaints groups. Table 10
depicts the steps of this equation.
Table 10
Hierarchical linear regression analysis describing score differences between the Social
Security disability (n = 30) and comorbid complaints (n = 66) groups
Model
Step 1
RC2
Step 2
RC2
MLS
Step 3
RC2
MLS
L-r

Adj. "!

D"!

b

.076

.086

.293

.015

.167
.177

.059

.128
.218
.245

.082

.133

The six MMPI-2-RF scales whose scores differed significantly between the Social
Security disability group and the psychological complaints group were entered into the
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second regression analysis in the following order: RC2, NUC, MLS, SUB, RC1, and L-r.
Results of this second analysis demonstrated that the six aforementioned scales
collectively accounted for 30% of the variance in score differences between the Social
Security disability compensation and psychological complaints groups. Table 11
demonstrates the steps of this equation. Notably, the first four steps accounted for
approximately 24% of the variance between these two groups.

(continues)
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Table 11
Hierarchical linear regression analysis describing score differences between the Social
Security disability (n = 30) and psychological complaints (n = 58) groups
Model
Step 1
RC2
Step 2
RC2
NUC
Step 3
RC2
NUC
MLS
Step 4
RC2
NUC
MLS
SUB
Step 5
RC2
NUC
MLS
SUB
RC1
Step 6
RC2
NUC
MLS
SUB
RC1
L-r

Adj. "!

D"!

b

.110

.120

-.347

.168

.066

-.248
-.276

.002

-.289
-.313
.078

.083

-.225
-.320
.032
.293

.002

-.212
-.359
-.021
.291
.090

.078

-.174
-.400
-.147
.179
.162
-.313

.160

.237

.230

.304
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A simple linear regression was conducted to determine the explanatory power
SUB had in distinguishing between the psychological complaints group and the comorbid
complaints group. Results of this analysis indicated SUB accounted for approximately 4%
of the variance between these groups. Table 12 displays these results.
Table 12
Simple linear regression analysis describing score difference between the psychological
complaints (n = 58) and comorbid complaints (n = 66) groups
Model
Step 1
SUB

Adj. "!

D"!

b

.035

.043

.206
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Discussion
In the past two decades, vast increases in the number of patients presenting with
comorbid physical and mental health concerns in various healthcare settings have been
noted. Similarly, the number of Social Security disability compensation cases has
increased from approximately 6,000,000 cases in 2000 to approximately 10,000,000
cases in 2018 (Social Security Administration, 2018), which represents a 66% increase
over a comparable timespan. For these reasons, greater research focusing on these
populations is warranted. Numerous studies have been conducted on comorbid physical
and mental health conditions and, to a lesser degree, on Social Security disability
compensation seekers in the realms of medical and psychological research. The MMPI
instruments in particular have an extensive history of use for research purposes with
health-related populations, including applicants for Social Security or Veterans benefits.
However, room for further study remains; for instance, the MMPI-2-RF’s research base is
still developing, as it is the newest addition to the MMPI family. The MMPI-2-RF,
relative to its predecessor the MMPI-2, contains a greater number of scales related to
somatic and physiological disturbances and lends itself well to use with health-related
populations, as was demonstrated in the current study.
The primary goal of this study was to examine differences in MMPI-2-RF scale
scores between outpatient therapy clients presenting with comorbid physical and mental
health concerns, those seeking or receiving Social Security disability compensation, and
those presenting only with psychological concerns. Individuals with comorbid physical
and mental health diagnoses and those seeking or receiving Social Security disability
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compensation were of central interest in this study; the psychological complaints group
was included to provide a point of comparison to the other two groups. It was anticipated
that individuals in the comorbid conditions group would demonstrate pronounced somatic
complaints due to the nature of their presenting problems and/or preexisting
medical/health conditions. Somatic complaints were also expected to be exhibited by
those in the Social Security disability compensation group, but with higher scores
throughout the entire MMPI-2-RF profile (i.e., on validity scales and psychological
complaints scales as well as somatic complaints scales).
The rationale for these projected directions was based on possibilities suggested
by prior research: (a) Individuals applying for or receiving disability benefits may be of
the opinion that reporting impaired physical functioning is more believable (and therefore
more likely to lead to receiving or maintaining disability-related benefits) than reporting
diminished psychological functioning (e.g., Pollack & Grainey, 1984); (b) such
individuals may be motivated by secondary gain (e.g., financial compensation, attention
and nurturance from others) and may engage in exaggeration or malingering of symptoms
as a means to achieve these gains (e.g., Aguerrevere et al., 2018; Chmielewski et al.,
2017) and; (c) furthermore, it is possible that disability-seeking and –receiving
individuals at least partly define their identities in terms of their functional impairments.
The psychological complaints group was expected to display high scores on several
scales related to psychological symptoms, and it was anticipated that some somatic
symptoms may also be present to a lesser extent (e.g., as in the case of physical
expression of psychological symptoms).
112

Preliminary results of this study revealed several MMPI-2-RF scale scores were
high (i.e., T ³ 60) for all three groups, indicating that the MMPI-2-RF captures
disturbances in functioning regardless of whether a person is presenting with comorbid
complaints, purely psychological complaints, or is applying for or receiving disability
compensation. Overall, 11 scales assessing internalization of emotions, negative
emotionality, and somatic/cognitive symptoms (i.e., EID, RCd, RC2, AXY, SFD, NFC,
INTR-r, RC1, MLS, GIC, and COG), as well as three of the eight validity scales (i.e., F-r,
Fs, and FBS-r), emerged as being clinically relevant (i.e., T ³ 60) across the three groups.
Collectively, these 11 scales assessing symptomology measure disturbances in mood and
affect, including negative affect, anxiety, and poor self-esteem, along with assorted
physical health complaints. These similarities in MMPI-2-RF score patterns across
groups are not surprising and were, in fact, anticipated, given that symptoms of physical
and mental conditions often overlap.
The observed overlap in this study demonstrates that distinguishing between
disorders can be difficult, as would likely be attested to by mental health and medical
providers. A mix of psychological and somatic features can potentially be present in any
number of conditions or individuals. Furthermore, it should be noted that although
individuals with comorbid physical and mental health, Social Security disability, and
psychological concerns may endorse some similar symptoms on a test such as the MMPI2-RF, the underlying causes or reasons for their choice of symptom endorsement are not
necessarily the same. For instance, an individual diagnosed with depression and IBS may
demonstrate high scores on RCd, RC1, RC2, GIC, and NEGE-r, as these scales reflect
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symptoms and experiences consistent with these diagnoses. An applicant or recipient of
disability benefits may obtain high scores on these same scales without necessarily
experiencing either of these conditions in an effort to obtain monetary compensation or
other forms of secondary gain, although such an individual may also be affected by
genuine physical and/or psychological ailments. The important point is that personality
test results are primarily descriptive and examiner skill is essential for determining the
underlying intentions and motivations of test respondents, and it is possible to observe
differentiating features in MMPI-2-RF profile patterns.
The central analyses indicated that mean scores for some scales - approximately
12%, or six out of the 49 scales assessed - were significantly different across the three
groups. Specifically, five scales related to emotionality, somatic and cognitive symptoms,
and externalizing behaviors (i.e., RC1, RC2, MLS, NUC, and SUB) and one Validity scale
(i.e., L-r) emerged as being notably different among the three subsamples. The group of
five scales that differed in scores across the three groups broadly represented somatic,
emotional, and substance use disturbances. Between-groups analyses determined
statistically significant differences in MMPI-2-RF scale scores between the Social
Security disability compensation and comorbid complaints groups, between the Social
Security disability compensation and psychological complaints groups, and between the
psychological complaints and comorbid complaints groups. Three of the 49 scales
assessed, or approximately 6% of the scales (i.e., RC2, MLS, and L-r), had significantly
different scores between the Social Security disability compensation and comorbid
complaints groups. In terms of their measured characteristics, these scales reflect
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negative emotionality and physical concerns. Six out of 49 scales, or roughly 12% of the
scales assessed (i.e., L-r, RC1, RC2, MLS, NUC, and SUB), were significantly different
between the Social Security disability compensation group and the psychological
complaints group. These scales broadly reflect negative affect and specific physical
concerns. SUB was the only scale out of the 49 assessed (i.e., 2%) that was significantly
different between the psychological complaints and comorbid complaints groups. While
these percentages do not represent the majority of the scales assessed, they signify
differences between the three groups. Specifically, the Social Security disability
compensation group consistently scored higher than the comorbid complaints group on
all three scales mentioned previously. However, collectively these scales accounted for
only a small percentage (i.e., 13%) of the variance between these two groups. The Social
Security disability compensation group also scored higher on five of the six
aforementioned scales than the psychological complaints group, which accounted for a
robust 30% of the variance between these groups. It should be noted, however, that a
large portion of the variance between these groups (i.e., roughly 24%) was accounted for
by four scales, RC2, NUC, MLS, and SUB, broadly reflecting physical and emotional
concerns or discomfort and problematic substance use. While these latter results offer
parsimony and may suffice in demonstrating the variance between the Social Security
disability and psychological complaints groups, greater confidence in the differentiation
between these two groups can be had when considering the effects of all six scales
together. The psychological complaints group also scored higher than the comorbid
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complaints group on SUB, which accounted for a small (i.e., 4%) percentage of the
variance between these groups.
In broad terms, these findings demonstrate the general utility of the MMPI-2-RF
in identifying differences between various groups. For instance, the differences between
the Social Security disability compensation and comorbid complaints groups were
primarily in terms of reporting low positive emotionality and a general sense of poor
health, such that the Social Security disability compensation group reported greater
disturbance in these domains. The nature of the differences between the Social Security
disability compensation and psychological complaints groups entailed a stronger sense of
disturbances in mood and somatic symptoms in the former group. It should be noted,
however, that the Social Security disability compensation group did not report any
substance use-related problems, while the psychological complaints group did. This
particular result may be indicative of the Social Security disability compensation group’s
desire to be perceived as being inflicted with disabling difficulties that were not of their
choosing, rather than engaging in behaviors that could be construed as volitional. The
comorbid complaints and psychological complaints groups also differed in terms of
reported intensity and breadth of somatic symptoms and substance use-related problems.
It is probable these findings relate to the nature of the comorbid complaints group’s
presenting concerns and the higher frequency of co-occurring substance-related and
psychological disorder and purely substance-related disorder diagnoses among the
psychological complaints participants than among the comorbid complaints participants.
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One might expect the comorbid complaints group to have reported the greatest
disturbance (i.e., higher MMPI-2-RF scale scores) due to the complex nature of their
conditions, but in fact, the Social Security disability compensation group generally
obtained higher scores than the other two groups. This finding was not hypothesized, but
is indicative of the intensity of the latter group’s reported disturbance. As proposed
earlier, the difficulties reported by the Social Security disability compensation group may
have been amplified by a malingering component, the desire for secondary gain, and/or
formation of a disability-related identity. While the comorbid complaints group appeared
to report specific symptoms and experiences related to their conditions, the Social
Security disability compensation group appeared to demonstrate high scores reflective of
a general, broad-ranging disturbance. Previous research has not directly compared an
MMPI instrument’s scale scores between patients with comorbid conditions and
applicants or recipients of disability compensation as was done in this study; however,
similarity in terms of reported symptoms (e.g., symptoms of depression along with
somatic complaints) can be observed when comparing results of studies that used the
MMPI-2 or MMPI-2-RF with each population separately (e.g., Livingston et al., 2006;
Slesinger et al., 2002).
Each of the three groups in the current study demonstrated a pattern of high scale
scores in accordance with expectations. For instance, it was hypothesized that individuals
with comorbid physical and mental health conditions would report experiencing
symptoms of each ailment. Indeed, the comorbid complaints group in the current study
obtained high scores on scales assessing physical symptoms as well as negative
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emotionality, anxiety, and worry, which could be attributed to either the comorbidity with
mental health condition itself or distress or concern regarding a physical health condition.
This finding is similar to results from previous research on the use of the MMPI with
multiple sclerosis (MS) patients (Mayerink et al., 1988) in which the patients endorsed
“symptom items” from scales 1, 2, 3, 7, and 8 at a high rate (Mayerink et al., 1988). As
seen in the current study, the comorbid complaints sample of this study obtained high
scores on all somatic symptom-related scales. These MMPI-2-RF scales do not have
direct MMPI counterparts; however, several MMPI scales such as Clinical scales 1 and 3
contain somatic symptom items. The current results therefore demonstrate continuity
with earlier findings based on the MMPI. As also noted in previous research on the
relationship between physical and mental health, the two often contribute to and
compound one’s overall sense of disturbance. It is likely that this phenomenon underlies
the high score pattern observed in the comorbid complaints group’s MMPI-2-RF profiles.
Disability claimants may present with psychological or physical complaints or
some combination of the two in outpatient mental health settings. To illustrate this point,
the Social Security disability compensation group in the current study was primarily
seeking or receiving compensation on the basis of psychological disability; however,
some individuals reported physical disability or both physical and psychological
disability at time of intake. This was reflected in this group’s endorsement of both
somatic and cognitive symptoms on the MMPI-2-RF. Overall, the results for the Social
Security disability compensation group can be described as somewhat broader and more
intense than those of the other two groups. Similar findings have also been observed with
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use of the MMPI in the context of disability applications, such that state disability
applicants were found to demonstrate high scores on eight of the 10 Clinical scales
(Pollack & Grainey, 1984). In the current study, the Social Security disability
compensation group demonstrated the most high scores overall (i.e., T-scores ³ 60 on 20
of the 49 scales of interest).
The severity of the current Social Security disability compensation group’s
reported disturbance is made particularly evident by their high (i.e., T ³ 60) mean F-r
score, which was roughly 1 SD higher than those of the comorbid and psychological
complaints groups. Comparable results have been demonstrated in previous research
using the MMPI-2 and MMPI-2-RF validity scales in the context of disability
compensation (e.g., Bianchini et al., 2017; Chmielewski et al., 2017). The high F-r scores
seen in the current study as well as in prior research may be indicative of disabilityseeking or –receiving individuals attempting to demonstrate their need for such
compensation through heightened reporting of dysfunction. However, it cannot be
assumed from the current results that they are necessarily more impaired in their
functioning than individuals in the comorbid or psychological complaints groups, as an
index of level of impairment was not included in this study.
It may be expected that those experiencing psychological difficulties will
primarily have high scores on scales assessing these concerns; however, it would not
necessarily be surprising if such individuals were to also report physical symptoms (e.g.,
somatic expressions of stress or anxiety). This phenomenon has been observed in
previous research, for instance, in findings indicating that stress and depression can affect
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the development and progression of physical symptoms and conditions (APA, 2014).
Indeed, the psychological complaints group in the current study did report some somatic
symptoms, but they displayed fewer high scores on scales measuring these concerns than
the comorbid complaints and Social Security disability compensation groups.
Additionally, the psychological complaints group demonstrated a pattern of high scores
on scales assessing emotional dysfunction and negative emotionality, consistent with
their presenting concerns.
The exploratory stance of this study brought to light specific points of distinction
for each of the three groups individually. As briefly mentioned previously, the comorbid
complaints group was the only group to demonstrate high scores on STW and SAV. This
degree of difficulty in managing under pressure and avoidance of social activity may
speak to the severity of their physical symptoms/conditions, psychological
symptoms/conditions, or both, as in the compounding effect mentioned previously. The
Social Security disability group alone demonstrated T-scores ³ 60 on Fp-r, HLP, and
DSF. These findings speak to the high level of psychological disturbance, negative
emotionality, pessimism, and disturbances in interpersonal behaviors reported by this
group. Finally, the psychological complaints group was the only group to not obtain high
scores on HPC and NUC. These results were not necessarily unexpected, as each of these
two scales assess specific somatic/cognitive complaints. It was more surprising, however,
that the psychological complaints group did not demonstrate a score in the clinical range
on NEGE-r. This scale specifically assesses anxiety, insecurity, worry, and fear, which
are prominent features in numerous psychiatric conditions. Thus, this result introduces an
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unusual finding, given this group’s presenting problems. Additionally, the psychological
complaints group was the only group to demonstrate clinically relevant scores on RC4
and SUB (and, in fact, on any Externalizing scale). These findings are likely related to the
higher rates of diagnosed substance-related disorders in this group as compared to the
other two groups, as rule-/law-breaking and irresponsibility commonly occur in
conjunction with alcohol and drug use or misuse.
The current study offers several contributions to the field of personality
assessment. First, this study raises awareness to patterns examiners of disability cases can
attend to in testing scenarios involving the MMPI-2-RF. Assessment in these contexts
poses many challenges for the examiner; it can be difficult to know how much of what is
being reported by the examinee is genuine and how much may be propelled by
motivation for secondary gain, monetary or otherwise. Ultimately, individual differences
must be considered, and it is left to the examiner’s knowledge and expertise to make a
judgment on whether or not a disability claimant truly meets criteria for disability. The
results from this study do not resolve this challenge, but it is hoped they shed light on this
particular task.
This study demonstrates continuity with previous research on the use of the
MMPI-2 and MMPI-2-RF with similar populations, but also delves into newer territory,
as there is no current published study on profile differences between Social Security
disability-seeking or-receiving individuals and those with comorbid physical and mental
health conditions with either instrument. This study revealed symptom presentation on
MMPI-2-RF profiles can appear very similar among various health-related populations,
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which was particularly true when comparing the comorbid complaints and Social
Security disability compensation groups. Nonetheless, the MMPI-2-RF can be used to
identify differences among these individuals, as was also demonstrated by this study’s
findings. Ultimately, based on the results of this study, one could expect:
(a) Persons with comorbid physical and psychological conditions to report a number of
specific symptoms related to each set of ailments;
(b) Those seeking or receiving disability benefits to report a broad range of dysfunction
encompassing psychological and somatic concerns, as well as high levels of disturbance;
(c) Those experiencing purely psychological ailments to primarily report psychological
disturbance, with any expressed somatic concerns reported likely being a secondary
component related to the psychological disturbance.
Although this study offers new findings and provides an extension of the existing
research base on use of the MMPI-2-RF with health-related populations, it had some
limitations. Specifically, it was limited by the inability to assess for impairment of
psychological functioning and malingering in the Social Security disability compensation
group. Assessment of these factors is particularly relevant to individuals seeking or
receiving disability compensation due to the complexity of their underlying reasons for
selecting their responses (e.g., actual concerns or symptoms versus overstatements of the
same). As malingering and impairments in psychological functioning could not be
assessed in the current sample due to the archival nature of the dataset, it is difficult to
ascertain whether this group’s overall higher MMPI-2-RF scale scores relative to those of
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the other two groups were due to genuine distress and difficulty, or if these scores were
instead related to exaggeration of symptoms.
It should be noted that the mean age of the overall sample was approximately 40
years old, an age that falls within middle adulthood. This average age is likely due, in
part, to the removal of 30 participants aged 18, 21, and 23 from the psychological
complaints group, as previously discussed. As such, the results of this study may be more
generalizable to middle-aged and older adults rather than young adults. The results of this
study may also be limited in their generalizability to the broader populations represented
by each of the participant groups due to the size of each group. This is particularly true
for the Social Security disability complaints group, as it consisted of the fewest
participants (i.e., n = 30).
The current study provides a helpful starting point for future research. Future
research might consider incorporating a measure to assess functional impairment
secondary to psychological disturbance, particularly for individuals seeking or receiving
disability compensation or benefits. In fact, this would be an important step in clinical
evaluations that are directed toward affirming or disaffirming the presence of
psychological disability in disability compensation-seeking individuals. Future research
may also be directed to identifying optimal cut-off scores on MMPI-2-RF scales for
Social Security disability-seeking persons to further aid in establishing a more accurate
differentiation between disability and malingering. Another fruitful direction for future
research could involve establishing the predictive value of MMPI-2-RF scale scores in
determining compliance with medical regimens and predicting recovery from medical
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illness. Such research and clinical application directions speak to the potentially
expanding utilization, role, and relevance of the MMPI-2-RF in a variety of healthcare
contexts.
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Appendix: Participant Informed Consent Form
Informed Consent
Client Records Confidential Statement
[Clinic] is an outpatient psychology clinic composed of faculty and graduate students of
[university]’s School of Psychology Clinical Psychology program. Your clinician is
completing the requirements for his/her doctoral degree in clinical psychology under the
direct supervision of a licensed psychologist. [Clinic] has a dual mission to provide
comprehensive services to our clients as well as training for our graduate students. Please
feel free to ask any questions or voice concerns so that our professional relationship will
be open and satisfying for all.
Confidentiality:
We abide by the laws and certifying board regulations concerning confidentiality.
Therefore, you may be asked at times to sign a release that would allow us to give (or
receive) information to (or from) a physician, school, or other source. That release may
also be canceled by you at any time and no further communication would be allowed.
Also, you may refuse to give us permission to disclose information.
Special laws that allow for the release of confidential or privileged information have
been enacted in an effort to provide protection for the client and the public in
unusual circumstances. Personal information about the client may be released
without consent to the appropriate parties involved.
Those exceptions to privacy, privileged communication, and confidentiality include:
a. If there exists a danger of harm to the client or someone else;
b. If the client needs to be involuntarily hospitalized due to the debilitating
effects of mental illness or alcoholism;
c. If the client is required to undergo a court ordered examination;
d. If the client discloses information about the abuse or neglect of a child;
e. If the client discloses information about the abuse, neglect, or exploitation of
an aged or disabled adult;
f. If the client’s mental or emotional condition is presented as a legal defense;
g. If a civil, criminal, or disciplinary action arises from a complaint filed in
behalf of the client against a mental health professional in which case the
disclosure and release of information shall be limited to that action;
h. If it is disclosed that the client tests HIV positive (if he/she tests positive for
having been exposed to the AIDS virus), it may then be considered necessary
to notify the client’s significant other(s) of the positive test results and facts
about transmission.
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Emergency: In case of a non-medical emergency, call the [clinic] at [phone number]. If
for any reason contact is not made, we encourage you to call 911 or [emergency number
at psychiatric hospital], or go to the Emergency Room of the nearest hospital where you
will receive attention.
Informed Consent for Treatment:
By my signature below, I signify that:
1) I understand that the records of my evaluation and treatment are private and
confidential.
2) I understand that my medical records may be shared with other health care providers
at [clinic] as well as graduate students in [university]’s Clinical Psychology program
for the purposes of diagnosis, education, research, and supervision.
3) I understand that if my information is selected for use in any psychology-related
research projects, the information would be presented anonymously, and my name
and personally identifying information would not be used.
4) I have been given the opportunity to discuss these concepts and conditions and to ask
for clarification.
5) I understand that I will be informed of the goals, expectations, procedures, benefits,
and possible risks involved with counseling or evaluation process.
6) I have the right to refuse or withdraw from any counseling, psychotherapy, or
evaluation procedure or intervention unless otherwise specified by law.
7) I should question any procedure, intervention, rationale, or discussion that is unclear
or that I do not understand.
8) I understand that all communication will be private, legally privileged, and
confidential unless otherwise specified by the special laws presented above or unless I
provide my written consent to a specific release of information. I understand that if
my clinician is a student, then my treatment will be discussed with a supervising
psychologist and a supervision treatment team.
9) I understand that this consent may be withdrawn by me at any time without prejudice.
I hereby give my consent for service to be provided under the conditions above. I have
been given a copy of the Notice Of Privacy Practices to inform me about my rights and
policies of use and disclosures of Protected Health Information.
_____________________________
Client’s Name

__________________ _____________________
SS#
Date of Birth

_________________________________________________ _____________________
Client’s Signature
Date
_________________________________________________ _____________________
Witness
Date
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